Post on 24-Jun-2020
UNIVERSIDADE DE LISBOA
FACULDADE DE MEDICINA
The Neuroprotective Effect of BDNF on Oxidative DNA Damage in Rat Cortical Neurons: Evaluation by Comet Assay
Rúben Balau Delgado Gonçalves
Mestrado em Neurociências
Lisboa, 2012
UNIVERSIDADE DE LISBOA
FACULDADE DE MEDICINA
The Neuroprotective Effect of BDNF on Oxidative DNA Damage in Rat Cortical Neurons: Evaluation by Comet Assay
Rúben Balau Delgado Gonçalves
Orientador: Professora Doutora Ana Sebastião, FMUL Co-Orientador: Professor Doutor João Ferreira, FMUL
Todas as afirmações contidas neste trabalho são da exclusiva responsabilidade do candidato, não cabendo à Faculdade de Medicina da Universidade de Lisboa qualquer responsabilidade.
Mestrado em Neurociências
Lisboa, 2012
Esta dissertação foi aprovada pelo Conselho Científico da Faculdade de Medicina da Universidade de Lisboa em reunião de 19 de Fevereiro de 2013
Index
Abstract ................................................................................................................................... i
Resumo .................................................................................................................................. ii
Abbreviations List .................................................................................................................. iii
Figures Index .......................................................................................................................viii
Agradecimentos .................................................................................................................... xi
1. Introduction......................................................................................................................... 1
1.1 - BDNF and Other Neurotrophins .......................................................................... 1
1.2 - Oxidative Stress, ROS and DNA Damage ......................................................... 10
1.3 - Antioxidant Defences ........................................................................................ 15
1.4 - Ageing .............................................................................................................. 17
1.5 - Neurodegenerative Disorders and Oxidative Stress in Neurons ........................ 19
1.6 - Alzheimer’s Disease and Aβ Peptide ................................................................ 20
2. Objectives ........................................................................................................................ 25
3. Methodology ..................................................................................................................... 26
3.1 - Primary Cell Culture .......................................................................................... 26
3.1.1 - Culture Maintenance ................................................................................. 27
3.2 - Immunocytochemistry ....................................................................................... 27
3.3 - Cell Viability ..................................................................................................... 28
3.4 - Comet Assay .................................................................................................... 29
3.4.1 General Considerations ............................................................................... 29
3.4.2 Experimental Design.................................................................................... 33
3.4.3 Technique Description ................................................................................. 37
3.4.3.1 Electrophoretic Force (V/cm) Calculation .............................................. 38
3.4.3.2 Standard Cells ...................................................................................... 39
4. Results and Discussion .................................................................................................... 40
4.1 - The Oxidative Comet Assay: Implementation and Optimization ........................ 40
4.2 - Cell Culture Characterization: Are the cultured neurons viable at the times of
experiment? What percentage of glial cells is present in culture?.............................. 49
4.3 - Do neurons accumulate DNA damage, either structural or oxidative, as they
mature in culture? ..................................................................................................... 55
4.4 - Does Aβ25-35 peptide induce structural and/or oxidative DNA damage at sub-
lethal concentrations? ............................................................................................... 59
4.5 - Does BDNF protect against H2O2 induced DNA damage? ................................ 63
5. Conclusions ...................................................................................................................... 68
6. Future Work...................................................................................................................... 69
7. References ....................................................................................................................... 71
8. Annexes ........................................................................................................................... 76
Annex I – Comet Assay Protocol ............................................................................... 76
Annex II – Standard Cells Protocol............................................................................ 95
i
Abstract
Alzheimer’s disease is an increasing prevalent disease nowadays although its
underlying mechanisms are not fully understood. In addition to other factors, it is
known that the presence of amyloid-β peptide in the senile plaques of patients with
Alzheimer disease, oxidative stress and neurotrophic deprivation are involved in the
onset of the disease.
In vitro studies refer that incubation with BDNF prevented Aβ-induced apoptosis
and also increased the activity of antioxidant enzymes. However, most studies only
refer oxidative stress and the loss of cell viability and do not focus in oxidative
damage particularly to the nuclear DNA.
In this study, the structural and oxidative DNA damage of primarily cultured rat
cortical neurons was measured by Comet Assay. The assay was performed after
incubation with the Aβ25-35 peptide at sub-lethal concentrations for a 24 hour period
and after a 10 minutes exposure to 10 µM H2O2 in the presence or absence of BDNF.
Although no DNA damage was observed after incubation with the Aβ25-35 peptide,
the H2O2 incubation induced both structural and oxidative damage to the nuclear
DNA, while a 48 hour pre-incubation with BDNF decreased the induced oxidative
damage. This study thus provided a useful insight into BDNF’s protective effects on
DNA damage. However, further studies are necessary to evaluate if the Aβ25-35
peptide induces DNA damage at higher concentrations.
Keywords: Cortical neurons, BDNF, Aβ25-35 peptide, H2O2, Comet Assay, DNA
damage.
ii
Resumo
A doença de Alzheimer é cada vez mais prevalente actualmente devido ao
envelhecimento da população mundial, no entanto os mecanismos biológicos que
levam ao seu aparecimento ainda não são conhecidos. Entre outros factores, sabe-
se que a presença de agregados do péptido β-amilóide assim como o stress
oxidativo e deprivação neurotrófica estão envolvidos no desenvolvimento da doença.
Estudos in vitro demonstraram que a incubação com BDNF evita a apoptose de
neurónios induzida pelo péptido β-amilóide assim como aumenta a actividade de
enzimas antioxidantes. No entanto, a maioria dos estudos foca-se na presença de
stress oxidativo e na perda de viabilidade celular, não estudando os níveis de dano
ao DNA nuclear, especialmente de natureza oxidativa.
Neste estudo, o dano estrutural e oxidativo ao DNA nuclear de culturas primárias
de neurónios corticais de rato foi medido utilizando a técnica de Comet Assay. A
técnica foi realizada após incubação com o péptido Aβ25-35 em concentrações sub-
letais por um período de 24 horas e após exposição a 10 µM de H2O2 na presença
ou ausência de BDNF.
Apesar de nenhum dano ao DNA ter sido observado após incubação com o
péptido Aβ25-35, a incubação com H2O2 induziu dano estrutural e oxidativo ao DNA
nuclear sendo que uma pré-incubação com BDNF reduziu os níveis medidos de
dano oxidativo. O presente estudo permitiu então determinar que o BDNF tem um
efeito protector em condições de dano ao DNA. No entanto, são necessários mais
estudos para avaliar se o péptido Aβ25-35 induz dano ao DNA quando presente em
concentrações mais elevadas.
Palavras-Chave: Neurónios Corticais, BDNF, Péptido Aβ25-35, H2O2, Ensaio Comet,
Dano ao DNA.
iii
Abbreviations List
8-oxoG - 8-oxoGuanine
AD - Alzheimer’s Disease
Akt – also known as PKB (Protein Kinase B)
ANOVA - Analysis of Variance
AP sites - Apurinic/Apyrimidinic sites
APP - β-Amyloid Precursor Protein
araC - Cytosine Arabinoside
ATP – Adenosine Tri-Phosphate
Aβ peptide - Amyloid-β peptide
Aβ1-40 - Amyloid-β peptide 1-40
Aβ1-42 - Amyloid-β peptide 1-42
Aβ25-35 - Amyloid-β peptide 25-35
BAD - Bcl-2-associated death promoter (BAD)
Bax - Bcl-2–associated X protein
Bcl2 - B-cell lymphoma 2
Bcl-xL- B-cell lymphoma-extra large
BDNF - Brain-Derived Neurotrophic Factor
BER - Base Excision Repair
BSA - Bovine Serum Albumin
iv
CDK2 - Cyclin-dependent kinase 2
CDK3 - Cyclin-dependent kinase 3
DAG - Diacylglycerol
DAPI - 4’, 6’ – Diamidino-2-Phenylindole
DIV - Days In Vitro
DMEM - Dulbecco's Modified Eagle Medium
DMSO - Dimethyl sulfoxide
DSBs - Double-Strand DNA Breaks
EDTA - Ethylenediaminetetraacetic acid
EndoIII - Endonuclease III
ERK - Extracellular Signal-Regulated Kinase
EtBr - Ethidium bromide
Fapy - Formamidopyrimidines
FBS - Fetal Bovine Serum
FISH - Fluorescent in situ hybridization
FKHRL-1 - Forkhead Transcription Factor
Fpg - Formamidopyrimidine DNA Glycosylase
Gab1 - GRB2-associated-binding protein 1
GC-MS - Gas Chromatography-Mass Spectrometry
GDP - Guanosine Di-Phosphate
GFAP - Glial Fibrillary Acidic Protein
v
GPx - Glutathione Peroxidase
GR - Glutathione Reductase
Grb2 - Growth factor receptor-bound protein 2
GSH - Glutathione
GSSG - Glutathione Disulfide
GTP - Guanosine Tri-Phosphate
H2O2 – Hydrogen Peroxide
HBSS - Hanks’ Balanced Salt Solution
HEPES - 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
HPLC - High-Pressure Liquid Chromatography
IP3 - Inositol 1,4,5-Trisphosphate
IκB - Inhibitor of κB
KSR1 - Kinase Suppressor of Ras 1
LMPA - Low Melting Point Agarose
LY-294002 - 2-(4-Morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one (inhibitor of PI-3
kinase)
MAP2 - Microtubule Associated Protein 2
MAPK - Mitogen-Activated Protein Kinase
MEK - MAPK-ERK Kinase
Mn-SOD – Manganese Superoxide Dismutase
MPTP - 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine
vi
NADPH – reduced form of Nicotinamide Adenine Dinucleotide Phosphate
NF-κB - Nuclear factor kappa-light-chain-enhancer of activated B cells
NGF - Nerve Growth Factor
NMA - Normal Melting Agarose
NMDA - N-Methyl-D-aspartate
NT-3 - Neurotrophin-3
NT-4/5 - Neurotrophin-4/5
NT-6 - Neurotrophin-6
NT-7 - Neurotrophin-7
1O2 - Singlet Oxygen
O2•– - Superoxide Anion
Ogg1 - 8-oxo-Guanine-DNA Glycosylase
OH• - Hydroxyl Radical
OHdG - 8-hydroxy-2-deoxyguanosine
PBS - Phosphate Buffer Saline
PD - Parkinson’s Disease
PDL - Poly-D Lysine
Pen/Strep - Penicillin/Streptomycin
PI3-K - Phosphatidylinositol 3 - Kinase
PKC - Protein Kinase C
PLC-γ1 - Phospholipase C – γ1
vii
pRb - Retinoblastoma Protein
PTB - Phosphotyrosine-Binding
PtdIns (4,5)P2 - Phosphatidylinositol 4,5-Bisphosphate
RNAi - Interference RNA
ROS - Reactive Oxygen Species
SCGE - Single Cell Gel Electrophoresis
SH2 - Src Homology 2
SOD - Superoxide Dismutase
SOS - Son Of Sevenless
SSBs - Single-Strand DNA Breaks
TG - Thymine Glycol
TNF - Tumour Necrosis Factor
Trk - Tropomyosin-Related Kinase
U-0126 - 1,4-Diamino-2,3-dicyano-1,4-bis(2-aminophenylthio)butadiene (inhibitor of
MAPK)
U-73122 - 1-[6-[[(17b)-3-Methoxyestra-1,3,5(10)-trien-17-yl]amino]hexyl]-1H-pyrrole-
2,5-dione (inhibitor of Phospholipase C)
viii
Figures Index
Figure 1 – Neurotrophin interaction with Trk and p75NTR receptors. ............................ 2
Figure 2 – Neurotrophin signalling through Trk receptor activation. ............................ 4
Figure 3 – BDNF induced action in several signalling pathways after exposure to
NMDA or H2O2. ............................................................................................................ 8
Figure 4 – Hydroxyl radical (OH•) production in mitochondria through Fenton’s
reaction. .............................................................................................................. 11
Figure 5 – Stochastic causes of ageing. .................................................................... 18
Figure 6 – APP cleavage by secretase enzymes. ..................................................... 21
Figure 7 – Diagrams explaining the comet assay technique and mechanisms. ......... 31
Figure 8 – Representation of the analysis process used by comet analysis software
............................................................................................................................ 32
Figure 9 – Schematic representation of the comet assay timeline. ............................ 33
Figure 10 – Schematic representation of the comet assay timeline with a 24 hour
exposure to Aβ25-35. ............................................................................................. 34
Figure 11 – Schematic representation of the comet assay timeline with a 24 hour
exposure to Aβ25-35 and a 48 hour incubation with BDNF.................................... 35
Figure 12 – Schematic representation of the comet assay timeline with a 48 hour
incubation with BDNF and exposed to H202. ....................................................... 36
Figure 13 – Comet assay using the THP-1 cell line after incubation with etoposide for
one hour at several concentrations. .................................................................... 42
ix
Figure 14 – Graphic representations of the comet assay tail length data using the
THP-1 cell line after incubation with etoposide for one hour at several
concentrations. .................................................................................................... 43
Figure 15 – Graphic representations of the comet assay percentage of DNA in tail
data using the THP-1 cell line after incubation with etoposide for one hour at
several concentrations ........................................................................................ 44
Figure 16 – Image of comets obtained from primary cultured cortical neurons
exposed to H2O2. ................................................................................................. 46
Figure 17 – Graphic representations of the standard cells tail length and percentage
of DNA in tail data mean values. ......................................................................... 47
Figure 18 – Graphics of the fluorescence and absorbance data obtained at various
DIVs. ................................................................................................................... 50
Figure 19 – Overview of a neuronal culture ............................................................... 51
Figure 20 – Detail of an astrocyte at the centre of the image. ................................... 51
Figure 21 – Graphic representation of structural and oxidative DNA damage as the
neuronal culture matures. .................................................................................... 55
Figure 22 – Graphic representation of structural and oxidative DNA damage as the
neuronal culture matures. .................................................................................... 56
Figure 23 – Graphic representation of structural and oxidative DNA damage caused
in the presence of the Aβ25-35 and in the presence or absence of the B27
supplement. ......................................................................................................... 57
Figure 24 – Graphic representation of structural and oxidative DNA damage caused
in the presence of the Aβ25-35 and in the presence or absence of the B27
supplement. ......................................................................................................... 58
Figure 25 – Graphic representation of structural and oxidative DNA damage caused
by sub-lethal concentrations of Aβ25-35 ................................................................ 61
x
Figure 26 – Graphic representation of structural and oxidative DNA damage caused
by sub-lethal concentrations of Aβ25-35 ................................................................ 62
Figure 27 – Graphic representation of structural and oxidative DNA damage after
exposure to H2O2 with or without a pre-incubation with BDNF ............................ 64
Figure 28 – Graphic representation of structural and oxidative DNA damage after
exposure to H2O2 in the presence or absence of BDNF. ..................................... 65
Figure A – Outline of the slide cleaning and coating first steps ................................. 81
Figure B – Outline of the slide cleaning and coating last steps. ................................. 81
Figure C – Outline of the agarose embedment and cell lysis steps ........................... 84
Figure D – Outline of the staining steps. .................................................................... 90
xi
Agradecimentos
Quero agradecer à minha mãe e avó que me apoiaram imenso neste período da
minha vida. Por toda a paciência, carinho e amor, sem os quais não me teria sido
possível superar mais esta etapa.
Agradeço igualmente ao meu pai, pelos conselhos práticos e pela perspectiva que
proporcionou sobre o que verdadeiramente importa na vida profissional.
Estou profundamente grato à minha namorada pelo apoio, carinho e amor. Por
sempre me conseguir animar, mesmo nos dias de maior frustração e por me ter
aturado e ajudado a concentrar durante o processo de escrita, sem cujo apoio esta
dissertação não existiria.
Quero agradecer ao Prof. Doutor Alexandre Ribeiro, por me ter acolhido no
laboratório e me ter proporcionado esta oportunidade.
A todos os colegas de laboratório da UFN, e em especial ao Jorge Valadas, André
Santos e Pedro Pereira (UBCR), pelo apoio e conselhos práticos, o meu obrigado.
Um agradecimento especial à minha orientadora, Prof. Doutora Ana Sebastião,
pela liberdade e possibilidade de desenvolver trabalho com uma técnica não
previamente utilizada no laboratório, pela acessibilidade e disponibilidade e pelos
conselhos e orientação sempre pertinentes.
Agradeço igualmente ao Prof. Doutor João Ferreira, meu co-orientador, pelo rigor
e conselhos experimentais aquando da montagem da técnica.
Um agradecimento final ao Prof. Doutor Andrew Collins (U. Oslo) pela enzima FPG
e pelas sugestões referentes ao protocolo de comet sem as quais não teria sido
possível realizar o ensaio em neurónios.
1
1. Introduction
1.1 BDNF and Other Neurotrophins
Neurotrophins are a highly conserved family of secreted proteins that regulate brain
functions, particularly development, differentiation, survival and plasticity [23,55]. The
neurotrophin family includes the nerve growth factor (NGF), neurotrophin-3 (NT-3),
neurotrophin-4/5 (NT-4/5), neurotrophin-6 (NT-6), neurotrophin-7 (NT-7) and the
brain-derived neurotrophic factor (BDNF) [20, 50]. NT-6 and NT-7 were isolated from
fish and have no mammalian or bird orthologous but appear to interact with the same
receptors as the related proteins in mammals [44]. The effect of neurotrophins is
exerted through the binding to two different classes of cell surface receptors, the
tropomyosin-related kinase (Trk) receptor family composed by TrkA, TrkB and TrkC
receptors and the neurotrophin receptor p75NTR, which is a member of the tumour
necrosis factor (TNF) receptor family. While the p75NTR receptor allows the binding of
all mature neurotrophins, the Trk receptor family exhibits ligand specificity to each
receptor, namely NGF preferentially binds to TrkA, BDNF and NT-4 to TrkB and NT-3
to TrkC [25]. The p75NTR receptor is known to regulate the Trk receptors response to
neurotrophins. In the presence of this receptor, NT-3 has a diminished affinity to TrkA
and together with NT-4 is also much less effective at activating TrkB. The TrkA and
TrkB receptors ligand specificity is then enhanced by the p75NTR receptor which leads
to a higher affinity of these receptors to their primary ligands, NGF and BDNF,
respectively [23].
The BDNF protein is processed from a pro-protein to a mature form and it is the
mature form that binds specifically to the TrkB receptor leading to cell survival or
2
differentiation. Pro-BDNF and other proneurotrophins, on the other hand, can bind
with high affinity to the p75NTR receptor, activating signalling pathways that often
result in apoptosis [44].
As can be seen in Figure 1, the Trk receptors are highly conserved and present an
extracellular domain composed by a cluster rich in cysteine residues. These are
Figure 1 – Neurotrophin interaction with Trk and p75NTR receptors. Conserved protein
domains are present in Trk receptors (TrkA, TrkB and TrkC). NGF, NT-3, NT-4 and BDNF
neurotrophins have an equal low affinity to the p75NTR receptor, but their pro-protein form
binds with high affinity to this receptor. NGF binds preferentially to the TrkA receptor. BDNF
and NT-4 specifically bind to the TrkB receptor. NT-3 favourably binds to TrkC but in certain
situations, it also has a low affinity to the other Trk receptors. CR1-CR4: cysteine-rich motifs;
C1/C2: cysteine-rich clusters; LRR1–3: leucine-rich repeats: Ig1/Ig2: immunoglobulin-like
domains [44].
3
followed by three leucine-rich repeats, another cysteine-rich cluster and two Ig-like
domains. The transmembrane region of these receptors contains a terminal tyrosine
kinase domain that is surrounded by many tyrosine residues which allows the binding
of cytoplasmic adaptors and enzymes in a phosphorylation dependent way [50].
BDNF, as a member of the family of neurotrophins, then influences cell survival,
differentiation and death [5] by the activation of its high-affinity receptor, the tyrosine
kinase receptor B (TrkB) [20]. So far, three different TrkB receptors have been
described with different signalling capabilities: TrkB.FL, a full-length catalytic receptor
and two truncated isoforms of the latter, TrkB.T1 and TrkB.T2. The TrkB.FL is a
transmembrane tyrosine kinase receptor with a conserved intracellular domain that
interacts with several signalling pathways including the Ras/MAPK, PI3K and PLC-γ1
pathways. The TrkB.T1 and TrkB.T2 receptors allow a signal transduction but lack an
intracellular tyrosine kinase activity. The gene expression of BDNF and TrkB varies,
depending on the development stage, age and cognitive performance. During
development, the TrKB.FL protein levels increase and there is a reduction of the
expression of this receptor in the hippocampus of aged rats. A decreasing expression
of BDNF and its receptors in dendrites could then partially explain memory
impairment in aged animals [55].
The activation of the Trk receptors is stimulated by neurotrophin binding that
induces dimerization of these membrane proteins and ultimately leads to the
transphosphorylation of their tyrosine kinase terminal domain. Of note that this
activation only occurs if the neurotrophin bound to the receptor is in its mature form
and not in the pro-form. The several tyrosine residues present in the terminal domain
4
of the Trk receptors are also subject to additional phosphorylation by the tyrosine
kinase receptor domain. The phosphorylated tyrosines then allow the recruitment of
several adaptor proteins and enzymes that propagate the signal transduction. The
proteins that bind to these phosphotyrosines and surrounding amino acid residues
usually contain phosphotyrosine-binding (PTB) or Src homology 2 (SH2) domains [50].
One of the major Trk receptor activating pathways is the Ras pathway which is
required for normal differentiation of neurons as well as promoting neuronal survival.
The adaptor protein Shc is recruited by a phosphotyrosine residue in the Trk receptor
by interacting with its PTB domain. The Trk receptor then mediates the
Figure 2 – Neurotrophin signalling through Trk receptor activation. The main activated
signalling pathways are depicted. Neurotrophin (NT) binding to the Trk receptor leads to its
dimerization and consequently to autophosphorylation. The Ras/Raf/MEK pathway promotes
the expression of prodifferentiation genes whereas the PI3-K/Akt pathway leads to the
expression of prosurvival genes. Adapted from Skaper (2012) [50].
5
phosphorylation of a tyrosine residue in Shc which leads to the recruitment of another
adaptor protein, Grb2. Grb2 in turn bounds to the Ras exchange factor SOS (Son Of
Sevenless) which activates Ras by replacing GDP with GTP [44]. The activated Ras
protein then interacts with the serine-threonine kinase Raf which sequentially leads to
activation of MEK (MAP kinase- ERK (Extracellular signal-regulated) kinase) that
further activates MAPK (mitogen-activated protein kinase). The translocation of
activated MAPK to the nucleus leads to the phosphorylation of transcription factors
that promote neurons to differentiate [50] (see Figure 2). There is a feedback in the
MAPK signalling cascade that attenuates and terminates signal responses through
the phosphorylation of intermediates and activation of phosphatases. For example,
ERK mediates SOS phosphorylation resulting in the dissociation of the SOS-Grb2
complex [44].
Activation of the PI3-K (phosphatidylinositol 3 - kinase) pathway can occur in a
Ras-dependent way or in a Ras-independent way which involves the Gab1 factor.
Both activating pathways lead to the promotion of neuronal survival and growth [50].
As seen in Figure 2, the PI3-kinase Ras-independent activation is initiated by the
recruitment of Gab1 by the phosphorylated form of Grb2 which subsequently leads to
the binding and activation of PI3-K. Activated PI3-K generates P3-phosphorylated
phosphoinosides, neuron survival essential lipids that are substract of many
phosphoinositide-dependent kinases that together with PI3-K activate the Akt protein
kinase. Through phosphorylation, Akt protein then controls the activity of several
proteins that are important in promoting neuronal survival. These proteins include
BAD and Bcl2-family members that are substrates that directly regulate the caspase
6
signal transduction pathway by binding to Bcl-xL, thus preventing this factor from
inhibiting the pro-apoptotic activity of the Bax protein. Phosphorylation of BAD leads
to its sequestering by the 14-3-3 proteins which prevents its pro-apoptotic actions.
Akt also regulates the activity of the forkhead transcription factor (FKHRL-1)
transcription factor by phosphorylation leading to the cytoplasmic sequestering of its
phosphorylated form by 14-3-3 proteins. This, in turn, prevents FKHRL-1 from
activating the transcription of several genes, which had the purpose of promoting
apoptosis. Furthermore, the degradation of IκB is mediated by phosphorylation
induced by the Akt protein, which leads to the liberation of the NF-κB factor that
promotes the transcription of genes involved in the sensory promotion of neuronal
survival [44].
PLC-γ1 (phospholipase C – γ1) activation results in the activation of two pathways:
the Ca2+-regulated pathway and the protein kinase (PKC)-regulated pathway. Both
ways lead to the promotion of synaptic plasticity [50]. The phosphorylated tyrosine
residues in the Trk receptor recruit PLC-γ, activating it through Trk-mediated
phosphorylation which then leads to the hydrolysis of PtdIns (4,5)P2, generating IP3
and DAG (see Figure 2). The presence of IP3 induces the release of Ca2+ from
cytoplasmic stores while DAG stimulates the DAG-regulated isoform of PKC. These
two signalling molecules can potentially activate many intracellular enzymes,
including the majority of PKC isoforms, Ca2+ - calmodulin-dependent protein kinases
and other Ca2+ - calmodulin-regulated targets [44].
The activation of the MAPK signalling cascade and increased levels of ERK1/2,
has been shown to occur both by pro-survival stimulus such as BDNF and toxic
7
stimuli including oxidative stress and are, as such, not predictive of the effect upon
neuronal survival [15,52]. This effect has, however, been found to be dependent upon
ERK1/2 localization, possibly explaining a biphasic effect of MAPK activation
following oxidative injury in which ERK1/2 has a protective effect upon the DNA
through the glutathione metabolism in early stages and later, following long exposure
to oxidative agents, contributes to cellular toxicity and death [15,29]. These findings are
consubstantiated by Hetman et al (2007) that reports a BDNF dependent activation
of MAPK involving co-localization of ERK1/2 with Kinase suppressor of Ras 1 (KSR1)
in membrane vesicles resembling the Golgi. Despite this, ERK1/2 also suffers a initial
rapid nuclear translocation though to be necessary for cell cycle re-entry [15,54].
A recent study by N. Boutahar et al (2010) has concluded that BDNF protects
cortical neurons from oxidative stress through the Ras/MAPK pathway and proteins
E2F1 and Rb (Retinoblastoma protein). As post-mitotic cells, neurons pause in the
G0 phase of the cell cycle. To re-enter it, cell cycle proteins must be activated so that
neurons can exit G0 and enter G1 phase. However, protein activation may also
potentiate a cell death mechanism in which the re-entry in the cell cycle ends in
mitotic aberration and ultimately cell death. Proteins Rb and from the E2F protein
family are included in the group of factors that regulate the cell cycle progression. In
quiescent cells, protein Rb is mainly hypo-phosphorylated and sequesters
transcriptions factors from the E2F family, hence inhibiting the cell from re-entering
the cell cycle. In contrast, the hyper-phosphorylation of Rb leads to its dissociation
from the E2F1 transcription factor, allowing the activation of E2F1-responsive genes,
S phase progression and neuronal death [5].
8
The image in Figure 3 depicts the action of BDNF in signalling pathways after
exposure to NMDA or H2O2. The H2O2 exposure induced ERK activation and cell
death which was prevented by BDNF [5]. These results, together with the fact that the
PI3-K inhibitor tested in the paper had no effect on ERK activation, lead to the
conclusion that the PI3-K pathway was probably not involved in the activation of the
Ras/MAPK pathway when the cortical neurons were exposed to H2O2 [5]. Cortical
neurons treated with NMDA or H2O2 had an increase in phosphorylation of protein Rb
and E2F1 expression and this effect was completely abolished when these
neurotoxins were combined with BDNF, leading to the previously reported conclusion
that neuroprotection induced by BDNF also involves proteins Rb and the E2F1
transcription factor [5].
Figure 3 – BDNF induced action in several signalling pathways after exposure to NMDA
or H2O2. The PI3-K pathway was activated by BDNF. On the other hand, BDNF stopped both
the NMDA and H2O2 activated MEK pathway and the activation of proteins Rb and E2F1
induced by both compounds. NMDA induced expression of ER stress was not modified by
BDNF [5].
9
The conclusion that BDNF prevents ERK activation induced by toxic agents while
capable to induce ERK activation on its own is of particular interest. One must
consider that these kinases can be activated by several extracellular signals
transducing them to various effector mechanisms [54]. This includes the ability to
mediate suppression of apoptosis by neurotrophins [54] but ERK kinases also play a
major role in promoting cell cycle progression and particularly ERK1 and ERK2 are
involved in DNA damage response [63]. In cortical neurons, the activation of ERK1/2
by BDNF suppresses apoptosis induced by DNA damaging agents [54]. Although the
way DNA damage induces ERK activation is still poorly understood, the general
consensus is that MEK mediates ERK activation in DNA damage responses. The use
of MEK inhibitors lead to the inhibition of ERK activation induced by several
genotoxic agents but whether DNA damage activates MEK through Raf remains to
be elucidated. Of note that the impact of the MEK/ERK pathway on checkpoint
activation in DNA damage response is dependent of the cell type [63].
BDNF is known to protect neurons from excitotoxicity through a signalling pathway
that activates NF-κB, a transcription factor that not only induces the expression of
antioxidant enzymes such as Mn-SOD but also induces the expression of Bcl-2, an
anti-apoptotic protein [31]. Regarding the increase in the activity of antioxidant
enzymes, previous studies have indicated that BDNF increased the GPx (glutathione
peroxidase) and GR (glutathione reductase) activities. Neurotrophic factors can
protect neurons against oxidative insults and it has indeed been reported the ability
of BDNF to protect mesencephalic neurons against 1-methyl-4-phenyl-1,2,3,6-
10
tetrahydropyridine (MPTP) toxicity and hippocampal neurons against the
accumulation of ROS (reactive oxygen species) induced by glutamate exposure [32].
1.2 Oxidative Stress, ROS and DNA Damage
Oxidative stress is a state of imbalance in which cells might suffer oxidative
damage. The equilibrium between the biochemical processes that lead to the
production of reactive oxygen species (ROS) and the ones that dispose of such
oxidative compounds is thus impaired [53].
The brain is a relative small organ but its oxygen consumption can be as high as
20% of the body’s total basal oxygen consumption due to its high demand on the
ATP molecule. These high levels of oxygen intake then lead to high levels of ROS
and as such, neurons are exposed to a more oxidative environment than any other
cell type [53].
Reactive oxygen species (ROS) are a group of highly reactive molecules derived
from oxygen. These free radicals contain one or more unpaired electrons which allow
them to act as oxidizing agents. These molecules are more reactive than their
corresponding non-radicals and their presence leads to oxidative aggressions
towards any cellular biomolecules [33].
There is a continuous formation of ROS derived from the normal cellular
metabolism and as the result of some extracellular processes. Peroxisome
metabolism, enzymatic synthesis of nitric oxide, phagocytic leukocytes, heat,
11
ultraviolet (UV) light, therapeutic drugs, ionizing radiation and redox-cycling
compounds are some of the pathways and processes that produce ROS [3]. These
comprise a group composed mainly by hydrogen peroxide (H2O2), superoxide anion
(O2•–), singlet oxygen (1O2) and hydroxyl radical (OH•) [3,33].
In mitochondria, oxygen is mostly converted to water. However, during the
oxidative metabolism almost 2% of this oxygen can be converted into ROS and one
of the reactive species produced is the superoxide anion (O2•–). The superoxide
anion is relatively weak in aqueous media but can be converted to H2O2 either
spontaneously or catalysed by superoxide dismutase (SOD). The H2O2 can in turn be
completely reduced to water or partially reduced to hydroxyl radical (OH•), a very
powerful oxidizing agent. Although it is not as reactive as other ROS, H2O2 plays an
important part in the cellular oxidative damage and carcinogenesis processes as it is
a particularly stable molecule and diffuses easily across biological membranes. Thus,
H2O2 allows other cellular compartments to suffer oxidative damage, further
increasing the cellular injury, particularly if it is converted to the highly reactive
hydroxyl radical (OH•) [33].
Fe2+ + H2O2 � Fe3+ + OH- + OH• Equation 1
Fe3+ + O2•– � Fe2+ + O2 Equation 2
Figure 4 – Hydroxyl radical (OH•) production in mitochondria through Fenton’s
reaction. Equation 1 resumes Fenton reaction. Equation 2 resumes the reduction reaction of
Fe3+ ions. Adapted from Thomas et al (2009) [56].
12
During oxidative stress, the mitochondria can thus produce OH• through the Fenton
reaction. This reaction is depicted in Figure 4 as Equation 1 where low molecular
ions and iron ligands present in mitochondria react with H2O2 to form Fe3+ and OH-
ions as well as the hydroxyl radical (OH•). Fe3+ ions can then interact with another
ROS, the superoxide anion (O2•–) and reduce iron to Fe2+ ions resulting in molecular
oxygen (O2) being produced (Equation 2). The reaction in Equation 2 thus provide for
more Fe2+ ions that can be reused through Fenton’s reaction leading to a OH• influx
that can cause significant biological damage [56].
Despite the cells tendency to eliminate ROS, it is important to refer that these
molecules also play significant roles in the regulation of numerous physiological
processes such as platelet adhesion, neurotransmission and vascular permeability.
The free radical nitric oxide acts as a second messenger in these processes and it is
a highly diffusible molecule derived from L-arginine. In itself, nitric oxide is not highly
reactive to macromolecules, but it can react with the superoxide anion (O2•–) and
produce the strong oxidant peroxynitrate (ONOO–) [33].
The level of ROS in cells is thus inevitably increased as a consequence of the
metabolic stress. If the amount of ROS present in a cell is higher than their ability to
dispose of such reactive molecules, oxidative stress can occur and lead to several
damaging effects namely modifications of proteins, lipids and DNA which in turn lead
to mitochondria and cellular dysfunction [6].
Although ROS can cause damage to any cellular biomolecule, these can usually be
replaced and if their turnover is high, damage may not even accumulate. The DNA
13
molecule however, is the prime information molecule of the cell and nuclear DNA in
particular must last throughout the lifetime of the cell. As such, damage in the vital
molecule seriously threatens the cell function and must be repaired immediately [14].
Any modification to DNA changes its coding properties, the transcription and
replication processes and is thus considered as DNA damage. The lesions that the
DNA molecule can endure include apurinic/apyrimidinic (AP) sites, adducts, single-
strand DNA breaks (SSBs), double-strand DNA breaks (DSBs), crosslinks between
proteins and DNA and also mismatches by insertion or deletion of nucleotides [30].
AP sites are frequent DNA lesions in which the DNA bases are freed from the
deoxyribose backbone. They can be formed both spontaneously and as
intermediates during the process of repairing oxidized, deaminated or alkylated
bases. These AP sites are also one of the major types of damage produced by ROS
in DNA molecules. Approximately 50,000 to 200,000 AP sites can be found in a
mammalian cell induced by ROS action and in fact brain cells comprise most of these
AP sites [30].
DNA damage caused by ROS also includes common lesions such as 8-oxoguanine
(8-oxoG) and thymine glycol (TG). The levels of these lesions are increased in cells
treated with UV light, ionizing irradiation or chemical mutagens that generate oxygen
radicals. 8-oxoG lesions adopt a syn conformation and base pairs with adenine
leading to transversion mutations that can potentially play a role in the process of
ageing and the development of cancer. On the other hand, TG lesions strongly block
DNA replication and transcription and have to be efficiently removed and repaired to
14
maintain a genetic stability. The main DNA repair system that removes these types of
lesions is the base excision repair (BER) system [3].
These 8-oxoG lesions are included in the group of the most frequently studied
oxidized base lesions that also comprise the 8-hydroxy-2-deoxyguanosine (OHdG)
and 5-hydroxyuracil lesions. OHdG lesions can be generated from hydroxyl radicals
(OH•) which arise trough the hemolytic cleavage of H2O2 through the Fenton reaction
or by the decomposition of peroxynitrite (ONOO-), formed by the combination of
superoxide with nitric oxide. OHdG lesions accumulate in specific DNA sequence
sites and it is also postulated that in the genome of the human brain, DNA damage
occurs preferentially in some promotor regions. As previously mentioned, 8-oxoG
and OHdG DNA lesions are mutagenic as they mispair with adenine during the
replication and transcription processes. The accumulation of OHdG lesions in
preapoptotic neurons during retrograde degeneration and in prenecrotic neurons
during ischemic neurodegeneration have also been detected in well-characterized
animal models. 5-hydroxyuracil arises from cytosine oxidation leading to unstable
cytosine glycol which undergoes deamination. This lesion is also premutagenic as it
gives rise to C to T transitions resulting in base transversions [30].
Cells have developed several mechanisms to identify and repair DNA lesions,
which include the use of several DNA repair enzymes such as Endonuclease III
(EndoIII), formamidopyrimidine DNA glycosylase (Fpg) and 8-oxo-guanine-DNA
glycosylase (Ogg1) [13]. Of note that Ogg1 protein in eukaryotes is a DNA glycosylase
that removes 8-oxoG and other oxidized guanine bases from nuclear and
mitochondrial DNA and that is a function analogue of the Fpg protein in bacteria [39].
15
The DNA glycosylase Fpg has AP-lyase activity and specifically recognizes several
oxidized DNA bases including 8-oxoG, 8-oxo-adenine, formamidopyrimidine (fapy)-
guanine, fapy-adenine, 5-hydroxycytosine and 5-hdroxyuracil [64].
1.3 Antioxidant Defences
Antioxidants convert the oxidative compounds to less reactive species and
constitute the first line of defence against the ROS induced cellular damage. As the
ratio of steady-state concentration of oxidants to antioxidants increases, so does
oxidative stress. Cellular response to this type of stress includes DNA repair, cell
cycle arrest and apoptosis [33].
Cellular antioxidants include molecules such as glutathione, α-tocopherol (vitamin
E), carotenoids and ascorbic acid and antioxidant enzymes such as catalase and
glutathione peroxidase. If the levels of reactive oxygen species surpass the capacity
of these cellular antioxidants, then the cell is under the effect of oxidative stress [53].
Neurons, as any other cell type, contain specific enzymes to eliminate ROS from
the cytoplasm. As mentioned above, this enzyme group includes catalase,
glutathione peroxidase (GPx) and superoxide dismutase (SOD) [19].
There are several types of superoxide dismutase (SOD) enzymes depending on
the ion they contain. Copper-zinc-SODs are stable enzymes which are present in the
cytosol, particularly in lysosomes and the nucleus. Manganese-SODs (MnSODs) are
present in yeast and animal mitochondrias while iron-SODs have yet to be
discovered in animal cells [10]. SOD is an enzyme that converts superoxide anion
16
(O2•–) into hydrogen peroxide which, as previously mentioned can readily diffuse
through neural membranes [19].
Catalase activity is mostly located in peroxisomes in all cell types but it is
particularly concentrated in hepatocytes. The catalase enzyme reduces H2O2 to O2
and H2O, particularly when this reactive species is present in high concentrations. In
fact, catalase requires two H2O2 molecules to carry out this reduction reaction and as
such, when the H2O2 concentration is low, its enzymatic activity is reduced. For the
same reason, catalase activity is augmented as the H2O2 concentration increases
and it is very difficult to saturate the catalase enzyme [10].
The GPx enzyme is distributed throughout animal cells and its levels are higher in
the kidney, liver and whole blood. Its substract is the reduced form of glutathione
(GSH) which functions as an electron donor in the removal of H2O2 from the cell. GPx
is considered to be the main peroxide removing enzyme in human cells, presenting a
high specificity to GSH but not to H2O2, as it also reacts with other peroxides [10].
Thus, GPx is reduced, leading to the oxidation of GSH to GSSG, its disulfide redox
partner, ultimately leading to the removal of H2O2 from the cell. The glutathione
reductase (GR) enzyme is then responsible to recycle GSH from its oxidized form
(GSSG) by NADPH oxidation. The glutathione conversion GSH/GSSG is commonly
used as a biomarker of oxidative stress in biological systems. A decrease in
GSH/GSSG ratio could induce mitochondrial membrane structural damage, activity
changes in mitochondrial enzymes and membrane potential leading to mitochondrial
dysfunction and possibly affecting excitability in neurons [61].
17
1.4 Ageing
All organisms are subject to the ageing of its cells and tissues and eventually
death. The study of ageing is a complex area of research and is the result of various
interconnected cellular processes. Many theories have been proposed to explain
ageing, however many of them are not mutually exclusive – see Figure 5.
Two major groups exist within the theories of aging: the genetic and the stochastic
theories. The first are based on the finite number of population doublings of mitotic
cells mediated by the telomeres, while the latter proposes ageing as a consequence
of the accumulation of cellular damage owing to environmental exposure [43].
The somatic mutation theory was formulated by Medawar in 1952, soon after the
discovery of the DNA structure. This theory proposes that the gradual accumulation
of genomic DNA alterations is in the basis for ageing. Mutation in somatic cells that
occur before the reproductive age are select against, however, those that occur
afterwards are not as much as they do not impair the ability to produce descendants.
The rate of somatic mutations would then increase with age correlating to the
increase in mis-repaired DNA damage. These mutations could lead to the production
of abnormal proteins but there is no direct evidence of an age-dependent protein mis-
synthesis, although the rate of protein synthesis is known to be altered with aging
[43,59].
18
Although the somatic mutation theory has not been disproven and it is quite robust,
there is another theory which can better explain the source of cellular damage in
aging. This theory is termed oxidative theory of ageing which refers that aging occurs
as a consequence of the action of free radicals, namely ROS, produced by
mitochondria during the cellular respiration. ROS would then inflict damage upon
various cell organelles and biomolecules leading impaired functions. Most importantly
however, they would generate damage in the mitochondrial DNA leading to positive
feedback in ROS production [43,59].
Figure 5 – Stochastic causes of ageing. Illustration of various factors involved in cellular
ageing [43].
19
1.5 Neurodegenerative Disorders and Oxidative Stress in Neurons
As neurons consume substantial amounts of oxygen, have a low glutathione
content and a high proportion of polyunsaturated fatty acids, they are particularly
vulnerable to oxidative stress. Being postmitotic cells also implies that they cannot be
replaced if irreversible damage occurs. Accumulation of nuclear DNA damage in
neurons has been suggested as one of the main forms of brain aging and
neurodegeneration [6].
Neurodegenerative diseases onset and progression is thought to be dependent in
genetic factors, oxidative stress and the complex interactions between the individual
genetic background and environmental factors. The risks associated with each of
these factors are still poorly understood as well as the relation between neuronal
death and the diseases clinical expression. Neurodegenerative diseases are
characterized by site specific premature and slow death of determined neuronal
population. For example, in Alzheimer’s disease (AD), degeneration of neurons
occurs mainly in the nucleus basalis while, in Parkinson’s disease (PD), the affected
neurons are in the substantia nigra. It is also known that the neuronal populations
affected by neurodegeneration are usually synaptically interconnected, although the
mechanisms associated with the specificity that leads these neurons to cell death is
still not elucidated. Increasing evidence has been suggesting that this specificity may
be involved with alterations in the energy status of degenerative neurons, ubiquitin-
proteasome system defects, presence of aggregates of abnormal proteins (like β-
amyloid and tau proteins in AD), trophic factor deficiency, alterations in cytokine
levels and disruption of both ionic gradient and signal transduction processes [19].
20
1.6 Alzheimer’s Disease and Aβ Peptide
One of the most common neurodegenerative diseases is Alzheimer’s disease (AD),
characterized by mild cognitive impairments at onset and multiple cortical function
deficiencies in the later stages of the disease. Numerous senile plaques and
neurofibrillary tangles accompanied by neuronal death can be observed in the
dementia stages. These plaques are mostly composed of amyloid β peptide (Aβ
peptide). The Aβ peptide is a fragment of the β-amyloid precursor protein or APP,
containing 40 to 42 amino acid residues [2]. APP is a ubiquitously expressed
transmembrane glycoprotein and its secreted form, sAPP, is considered as a cell
survival signal with extensive influence on neuronal development. sAPP is released
in an activity-dependent manner promoting neurite outgrowth and preventing cell
death in hippocampal neurons [20].
As seen in Figure 6, the APP can be cleaved by three different secretase enzymes.
The α-secretase leads to the release of sAPP by cleaving APP in the centre of the β
amyloid domain whereas the β-secretase and γ-secretase action lead to the release
of the Aβ peptide. Following its release, the Aβ peptide can thus form aggregates.
Mutations in the APP gene inhibit the action of the α-secretase enzyme,
consequently allowing the β-secretase cleavage. Mutations in components of the γ-
secretase complex, the presenilin-1 and presenelin-2 (PSEN-1 and PSEN-2) genes,
also increase cleavage by the γ-secretase enzyme. The Aβ peptide production is
thus excessive and it is suggested that the soluble oligomers can impair synaptic
function between neurons. On the other hand, the Aβ aggregates may trigger a local
inflammatory response [40].
21
The APP cleavage by secretase enzymes can thus give rise to two main forms of
the Aβ peptide: Aβ1-40 which is the more soluble form of the Aβ peptide and Aβ1-42
which is the primary component of senile plaques and more neurotoxic than Aβ1-40 [8].
On the other hand, the neurofibrillary tangles are composed of paired helical
filaments aggregated, which in turn are formed by the hyper-phosphorylated form of
tau protein [38].
The amyloid β peptide is derived from APP through an initial β-secretase cleavage
which is followed by an intramembraneous cut by γ-secretase. An early onset of AD
has been associated with an autosomal dominant mutation in APP that results in
increased formation of the Aβ peptide. It is also known that, in primary neuronal
cultures, β-amyloid induces cell death. The tau protein is a microtubule-associated
Figure 6 – APP cleavage by secretase enzymes. The α-secretase cleaves APP in the
middle of the amyloid β domain leading to the release of the normal secreted form of APP.
When APP is cleaved by the β-secretase and γ-secretase it leads to the release of the Aβ
peptide which can thus form aggregates [40].
22
protein that contributes to the stability of these cell structures. The hyper-
phosphorylation of tau leads to the formation of neurofibrillary tangles, which
destabilizes the microtubule network, while its hypo-phosphorylated state has a high
microtubule affinity. This change in function of the tau proteins has been linked to the
disruption of neuronal function and alterations in the distribution of several organelles
including mitochondria [38].
Oxidative stress, inflammation and neurotoxicity are some of the results of Aβ
peptide accumulation in neurons. These processes can then lead to the deterioration
of the neurotransmission systems and ultimately to apoptosis [2]. In AD, the formation
and resulting effects of the senile plaques and neurofibrillary tangles has been
associated with oxidative stress and mitochondrial defects. The oxidation of proteins
often leads to altered protein solubility and hence, an increase in the formation of
protein aggregates. The cytotoxicity induced by multimeric Aβ peptide aggregates
can be explained by ROS production of copper ions which seem to be essential, in
vitro, for the Aβ1-42 inhibition of cytochrome C oxidase terminal complex. Tau protein
is also influenced by oxidative stress as its phosphorylation and aggregation
processes can be modulated by oxidative signals. Moreover, in primary hippocampal
neurons, tau phosphorylation is modified by iron-induced oxidative stress. In primary
neuronal cultures, oxidation by H2O2 induced the dephosphorylation of the tau
protein, but this is thought to have occurred as the concentration of H2O2 used was
high and it might have increased the over-oxidation of fatty acids that is known to
inhibit the polymerization of tau. In fact, another study using a lower H2O2
concentration reached the conclusion that H2O2 increases tau phosphorylation in
23
primary cortical neuron cultures, but the way the oxidative stress alters tau
phosphorylation is yet to be determined. The balance between kinases and
phosphatases does regulate the phosphorylated state of the tau protein and oxidative
changes in either of these enzymes are thought to create an imbalance between their
antagonist activities leading to tau hyper-phosphorylation [38].
The mechanisms by which the Aβ peptide causes cellular death are not fully
understood, however, as previously mentioned, oxidative stress is present in the
early onset of the Alzheimer’s disease (AD) pathology [53]. In in vitro studies, both
Aβ1-42 and Aβ25-35 peptides are known to play a role in oxidative stress leading to the
oxidation of several biomolecules [9,58]. The methionine in position 35 of the wild type
Aβ1-42 is necessary for the oxidative stress and neurotoxic proprieties of this peptide
and it is known to induce the reduction of copper ions (Cu2+) leading to the production
of H2O2 in the absence of cells [24]. The artificial peptide Aβ25-35 has similar oxidative
and neurotoxic proprieties but the mechanisms by which it acts are different. Aβ25-35
induces cell death much faster and its effects are more pronounced. Although this
peptide also displays the methionine 35 residue, its presence in the C-terminal alters
its proprieties and leads to no effect on the copper ion Cu2+, suggesting that the Aβ25-
35 induces oxidative damage by other mechanisms. Also, the presence of this residue
in the peptide is necessary for its oxidative proprieties as the truncated Aβ25-34
peptide, which lacks this terminal methionine, is known to be non-toxic and non-
oxidative [8,9].
A recent study by Arancibia et al has determined that BDNF induces a
neuroprotective effect against Aβ peptide toxicity, both in vivo and in vitro. The
24
collected data reported a dose-dependent toxic effect of β amyloid in cortical
neurons. Aβ25-35 was more toxic for cell survival than Aβ1-42 and although the
protection effect of BDNF had a dose-response result, it differed depending on the
peptide used for β amyloid toxicity. BDNF completely reversed the toxic action of
Aβ1-42 on neuronal survival whereas with Aβ25-35 this reversion was only partial [2]. As
previously mentioned, this neurotrophin can act as an antioxidant factor by increasing
the level of activity of several antioxidant enzymes [31]. As the neuronal loss after
amyloid β exposure, both in vivo and in vitro, can be explained by oxidative damage
caused by Aβ25-35, and that oxidative stress is present at the onset of AD, the
antioxidant defence provided by BDNF could explain its protective effect in Aβ toxicity
[55].
It has also been determined that BDNF and/or its TrkB receptor are impaired in
aging and in AD patients. Moreover, the production and signalling of BDNF in vivo
and in vitro is threatened by Aβ peptide which could ultimately lead to
neurodegeneration. On the other hand, neurons can be rescued from death by the
exogenous addition of this neurotrophin, as BDNF prevents Aβ-induced
neurodegeneration, both in vivo and in vitro [55].
25
2. Objectives
This study aims to determine if BDNF can protect neurons from structural and
oxidative DNA damage. Damage was induced by the Aβ25-35 peptide or by H2O2, a
known DNA damaging agent. As such, the following questions were posed:
o Do neurons accumulate DNA damage as they mature in culture?
o Does Aβ peptide induce structural and/or oxidative DNA damage at sub-
lethal concentrations?
o If Aβ25-35 has an effect on DNA integrity, can BDNF protect neurons
from this oxidative and/or structural damage?
o If Aβ25-35 has no effect, does BDNF protect neurons against the action
of another oxidative agent, such as H2O2?
26
3. Methodology
3.1 – Primary Cell Culture
Pregnant Sprague-Dawley rats, provided by a commercial company (Harlan
Interfauna Iberia, Barcelona, Spain), were anesthetized in a halothane chamber and
sacrificed by decapitation in accordance to the Portuguese animal handling laws.
Under sterile conditions, the 18 days of gestation embryos (E18) were removed from
the uterus and their brains harvested in cold dissection media (HBSS – Hanks’
Balanced Salt Solution – Ca2+ and Mg2+ free supplemented with 0.37% glucose).
After brain dissection and white matter removal, the cerebral cortex was placed in 2.7
mL of fresh dissection media. The cortexes were minced, Trypsin was added and the
minced tissue was incubated at 37ºC for 15 minutes. Cells were then precipitated by
a centrifuging step (188g, 5 minutes), the supernatant removed and cells
ressuspended in Neurobasal® (Gibco®) media supplemented with 10% FBS (Fetal
Bovine Serum), 25 U/mL Pen/Strep (Penicillin/Streptomycin), 0.5 mM glutamine, 2%
B27 supplement and 25 µM Glutamic Acid. The cells were further dissociated by
passing the solution through a pipette several times followed by filtration through a 70
µm cell strainer and ressuspension in Neurobasal® Media supplemented with 25
U/mL Pen/Strep, 0.5 mM glutamine, 2% of B27 supplement and 25 µM Glutamic
Acid. Cellular density was determined in a haemocytometer and neurons were plated
at 3x105 cells / mL (cellular density of 7x104 cells / cm2) in 6 or 24 well plates
previously coated with PDL (poly-D lysine). The cultures were maintained in a 37ºC
incubator with a 5% CO2 atmosphere.
27
3.1.1 – Culture Maintenance
The media used for cultured neurons was supplemented with B27, Pen/Strep and
Glutamine, but without Glutamic Acid. For the maintenance of cells in culture, the
media was changed twice a week, removing half of the culture media and
substituting it with fresh media supplemented with B27. Two days before the
experiment, all culture media is removed and fresh media is added in the absence of
B27 supplement. All cultures were maintained in a 37ºC incubator with a 5% CO2
atmosphere.
3.2 – Immunocytochemistry
For the immunocytochemistry experiments, 24 well plates with coverslips,
previously coated in PDL, were used. At the time of the experiment, the culture
media was removed and the coverslips transferred to another 24 well plate. The
coverslips were then washed twice with PBS (Phosphate Buffer Saline) for 5 minutes
to completely remove Neurobasal® media. Fixation of the DIV 5 and DIV 9 cultures
followed, being performed with a 4% paraformaldehyde solution in PBS for 15
minutes at room temperature. The fixation solution was completely removed by
aspiration and a solution containing 0.05% Triton X-100 in PBS added for 5 minutes
at room temperature. This permeating solution was then removed and substituted by
the blocking solution containing 0.25% gelatine in PBS for 40 minutes at room
temperature. After the removal, the coverslips were washed twice with PBS for 5
minutes. This was followed by 1 hour incubation with the monoclonal primary
antibody solution containing 0.05% Tween 20 and 0.1% gelatine in PBS. The primary
28
antibodies used were the anti-MAP2 (Microtubule Associated Protein 2) mouse
antibody (1:200) and the anti-GFAP (Glial Fibrillary Acidic Protein) rabbit antibody
(1:100). Coverslips were then washed twice with a PBS solution containing 0.05%
Tween 20 for 5 minutes, following which, incubation with the secondary antibody
solution for 1h, containing 0.05% Tween 20 and 0.1% gelatine in PBS was
performed. The anti-mouse secondary antibody (1:500) was conjugated with the
Alexa 488 fluorescent dye (green) and the anti-rabbit secondary antibody (1:500) to
the Alexa 568 fluorescent dye (red). Coverslips were again washed with a PBS
solution containing 0.05% Tween 20 and incubated with DAPI (4’, 6’ – diamidino-2-
phenylindole) (1:15000) for 5 minutes. This is followed by a washing step using the
0.05% Tween 20 in PBS solution and a final washing step using PBS. The coverslips
were then mounted in Mowiol® (Sigma®) before observation in the inverted
fluorescence microscope Axiovert® 200 (Zeiss®) and images captured using the
AxioCamMR3® (Zeiss®) digital camera.
3.3 – Cell Viability
To determine cell viability, a commercial kit named Alamar Blue® (Invitrogen®) was
utilized and the protocol was followed as instructed in the product’s manual. The DIV
1, DIV 5, DIV 9 and DIV 10 cultures were prepared in 24 well plates. The cells were
incubated for 1 hour with a 10% Alamar Blue® solution directly dissolved in the
culture media. All plates were automatically analysed in the Infinite M200® (Tecan®)
plate reader, using a gain of 85 and 25 flashes. Fluorescence values were obtained
using an excitation wavelength of 550 nm and an emission wavelength of 590 nm.
29
The absorbance values were obtained at 570 nm using the 600 nm wavelength as
reference.
3.4 – Comet Assay
3.4.1 – General Considerations
The comet assay, also called single cell gel electrophoresis (SCGE) was described
for the first time in 1984 by Ostling and Johanson. The basis of the assay, however,
relies on work published by Cook et al in 1976 as well as the work from Rydberg and
Johanson in 1978. In 1988 Singh et al described a version of the assay with
increased damage detection range by performing the electrophoresis in highly
alkaline conditions (pH>13) [16]. This version, the alkaline comet assay, quickly gained
popularity as a cheap, adaptable and highly sensitive technique to assess DNA
damage [42].
The comet assay is a versatile technique regarding the source of the biological
material. In fact, almost all types of cells can be used including cell lines, cultured
cells, frozen samples, tissue samples, plant cells and even sperm and prokaryotic
cells [42]. This technique is also very versatile regarding the type of DNA damage
measured as different versions of the assay can be used to observe different kinds of
lesions to the nuclear DNA. The original comet assay, with alterations from Olive et al
in 1990, labelled neutral comet assay, is able to measure both DSB and SSB, while
the alkaline version also measures AP sites in the genome. The comet assay can still
be further extended to measure even more types of DNA damage which is done by
incubating the DNA with lesion specific enzymes such as FPG, endonuclease III, T4
30
endonuclease V and Alk A. Other variants of the assay exist, such as the
Bromodeoxyuridine labelling version to detect replicating DNA, the version using
DNA synthesis inhibitors to detect intermediates of DNA repair and even Fluorescent
in situ hybridization (FISH) Comet to detect gene specific damage and repair [16,41].
A popular version is the oxidative comet assay, performed under alkaline
conditions (pH>13), in which the experimental conditions to be tested are performed
in duplicates with one of the two being incubated with FPG. Since this enzyme
recognizes and removes 8-oxoG lesions as well as ring-opened purines also called
Fapy (Formamidopyrimidines), this assay allows for the simultaneous determination
of structural and oxidative damage to the nuclear DNA [16].
The assay is also a very sensitive and cheap technique to perform, being able to
observe the DNA damage directly without having to rely on expensive antibodies. It
also obviates the need for special equipment such as for gas chromatography-mass
spectrometry (GC-MS) or high-pressure liquid chromatography (HPLC) while, in
addition, being free from these techniques oxidation artefacts which may result in
inaccurate measurements especially when measuring basal levels of oxidative DNA
damage [16]. As the assay is not standardized, its sensitivity and range differs
between different groups, however, Collins et al (2008) estimates this to be from 0.06
to 3 breaks per 109 Daltons of cellular DNA, corresponding to approximately 200 to
10000 breaks per diploid mammalian cell [18].
31
What experimental procedures comprise the alkaline comet assay however, and by
which mechanisms can the DNA damage be measured? The alkaline comet assay
entails the DNA electrophoresis of a population of cells embedded in a thin layer of
LMPA (Low Melting Point Agarose), which is liquid at 37ºC. This embedded
population of cells is subjected to lysis with a non-ionic detergent and high salt
concentrations, removing membranes, cytoplasm, nucleoplasm, disrupting the
A
B
Figure 7 – Diagrams explaining the comet assay technique and mechanisms. A –
Representation of main steps of the comet assay protocol [35]. B – Representation of the
comet assay comet formation process [48].
32
nucleosomes and removing almost all histones. What is left is the nucleoid, a scaffold
of proteins and supercoiled DNA as depicted in Figure 7 [16].
The supercoiled DNA may optionally be incubated with enzymes, such as FPG,
which will recognize and remove specific DNA damage, introducing a SSB. The
comet slides are then incubated in an alkaline solution causing DNA unwinding which
allows the relaxation of the supercoiled DNA. The electrophoresis then creates the
characteristic comet shapes as the more damaged the DNA is, greater DNA
migration into the comet tail will be observed. After staining with a fluorescent dye,
such as ethidium bromide, comet images are acquired and image analysis is
performed, subtracting the background fluorescence and analysing multiple
parameters such as the tail length and the percentage of DNA in tail as depicted in
Figure 8 [16,27].
Figure 8 – Representation of the analysis process used by comet analysis software. A
– Image of an acquired comet. B – Representation of the analysis performed by the image
analysis software on an acquired comet image [27].
A B
33
3.4.2 – Experimental Design
To answer the questions posed in the present work objectives, the experiments
were designed as follows:
o Do neurons accumulate DNA damage as they mature in culture?
To answer this question, the comet assay technique was performed on primary
cultured cortical neurons at DIV 5, DIV 9 and DIV 10. As described in Figure 9, at
DIV 3, the culture media was removed and replaced by fresh media without B27
supplement for the DIV 5 comet assay. Alternatively, half the culture media was
replaced by culture media with B27 supplement for the remaining experiments. At
DIV 7 and DIV 8, the culture media was completely removed and replaced by fresh
media without B27 supplement, and the comet assay was performed at DIV 9 and
DIV 10, respectively.
Figure 9 – Schematic representation of the comet assay timeline. Culture media
replacement and comet assay experiment dates.
34
o Does Aβ25-35 peptide induce structural and/or oxidative DNA damage at
sub-lethal concentrations?
For this second question, the same neuronal cultures were subjected to the comet
assay technique at DIV 5 and DIV 9 after a 24 hour exposure to sub-lethal
concentrations (0.3 µM, 1 µM and 3 µM) of Aβ25-35. As seen in the scheme of Figure
10, at DIV 3 the culture media was completely removed and replaced by fresh media
without B27 supplement. At DIV 4 the cultured neurons were exposed to the sub-
lethal concentrations of Aβ25-35 and at DIV 5 the comet assay was performed.
Alternatively, at DIV3, half the culture media was removed and replaced by media
with B27 supplement. At DIV 7 the media was completely removed, replaced by fresh
media without B27 supplement and at DIV 8 the cultured neurons were also exposed
Figure 10 – Schematic representation of the comet assay timeline with a 24 hour
exposure to Aβ25-35. Culture media replacement, Aβ25-35 exposure and comet assay
experiment dates.
35
to sub-lethal concentrations of Aβ25-35. The comet assay was then performed at
DIV 9.
As this second experiment could have had one of two outcomes, either DNA
damage was induced or not by the Aβ25-35 peptide, the following sub-experiments
were designed:
o If the Aβ25-35 has an effect on DNA integrity, can BDNF protect neurons
from this oxidative and/or structural damage?
As illustrated in Figure 11, the experimental conditions were the same as described
for the previous experiment with the exception of the incubation with BDNF. The
cultured neurons were incubated with this neurotrophin at 20 ng / mL for 48 hours
Figure 11 – Schematic representation of the comet assay timeline with a 24 hour
exposure to Aβ25-35 and a 48 hour incubation with BDNF. Culture media replacement,
BDNF incubation, Aβ25-35 exposure and comet assay experiment dates.
36
and the exposure to the Aβ25-35 peptide was performed 24 hours prior to the comet
assay.
o If the Aβ25-35 has no effect, does BDNF protect neurons against the
action of another oxidative agent, such as H2O2?
In the event that the Aβ25-35 induced no oxidative or structural damage, the cultured
rat cortical neurons were still incubated with BDNF at 20 ng / mL for 48 hours prior to
the comet assay. However, the cells were exposed to H2O2 instead of the Aβ25-35. As
seen in Figure 12, at DIV 3 half the culture media was removed and replaced by
culture media with B27 supplement. At DIV 8 the media was completely removed and
replaced by fresh media without B27 supplement in the presence or absence of
Figure 12 – Schematic representation of the comet assay timeline with a 48 hour
incubation with BDNF and exposed to H202. Culture media replacement, BDNF
incubation, H2O2 exposure and comet assay experiment dates.
37
BDNF. At DIV 10, the cultured neurons were exposed to 10 µM of H2O2 for 10
minutes prior to the comet assay.
3.4.3 – Technique Description
For the comet assay experiments, Superfrosted Rosa® slides were dipped in
absolute ethanol and passed over a blue flame. They were covered with a 1% NMA
(Normal Melting Agarose) in PBS solution, flattened with a 24x60 mm coverslip to a
thin gel layer and let o/n (overnight) to dry. After being subjected to the experimental
conditions in culture, neurons were washed twice with ice cold PBS, scrapped and
recovered to 15 mL Falcon tubes placed on ice. Following the centrifuging step
(700g, 10 minutes, 0ºC), the supernatant was removed and the cells were
ressupended in ice cold PBS. The neurons were then embedded in a 0.7% LMPA
(Low Melting Point Agarose) in PBS solution at 37ºC. The cell solution was carefully
placed over the NMA layer and flattened with a 24x60 mm coverslip. Coverslips were
removed and the slides placed in ice cold lysis solution (2.5 M NaCl, 100 mM EDTA,
10 mM Tris, 1% Triton X-100, pH 10) for 1 hour and 30 minutes. After retrieval from
the lysis solution, slides were washed three times with the FPG buffer (100 mM KCl,
40 mM HEPES, 500 µM EDTA, 200 µg/mL BSA, pH 8). Half were then incubated
with the FPG enzyme solution (1:3000 in FPG buffer) and the other half with the FPG
buffer alone for 30 minutes at 37ºC. The slides were transferred to the
electrophoresis chamber where they were immersed for 20 minutes in the
electrophoresis buffer (300 mM NaOH, 1 mM EDTA, pH > 13) to allow for DNA
unwinding. After this, an electric field with a voltage of 25 V (Volts) and a 300 mA
38
(mili Ampers) current was applied for 30 minutes (1.48 V / cm). Following removal of
the slides from the electrophoresis chamber, these were covered by the
neutralization solution (400 mM Tris, pH 7.5) for 5 minutes, repeating this step three
times. The agarose gels were then dehydrated in an alcohol series (70%, 95% and
100% ethanol solutions) for 5 minutes in each, and allowed to dry o/n at room
temperature. Staining was performed by covering the slides with a 0.4 µg / mL
Ethidium Bromide (EtBr) solution. Images were acquired in the Axiovert 200M®
(Zeiss®) microscope using the Coolsnap HQ CCD® (Roper Scientific®) 12-bit digital
camera. Image processing and analysis was achieved with Image J® (National
Institute of Health, USA) and with the Casp (Comet Assay Software Project) software.
Data and statistical analysis was performed using the GraphPad Prism® (GraphPad
Software®) program and expressed as mean ± SEM (Standard Error of the Mean).
The one way ANOVA (Analysis of Variance) statistical test followed by the Bonferroni
correction for multiple comparisons was chosen for analysis. Values were considered
statistically significant when the p-value was below 0.05. (For a more detailed
protocol of the performed technique please refer to Annex I)
3.4.3.1 – Electrophoretic Force (V / cm) Calculation
The electrophoretic chamber was measured and the determined dimensions were
introduced to an excel sheet available at: http://comics.vitamib.com/electrophoresis-
physics. The volume of buffer used was also introduced as well as the inner
electrophoresis chamber platform dimensions which allowed the calculation of the
electrophoretic force applied.
39
3.4.3.2 – Standard Cells
A culture of primary neurons was plated in a 143 mm2 Petri dish at a cell density of
9x105 cells / mL. At DIV 3, the cultured neurons were treated with 30 µM of H2O2 for
30 minutes, on ice. The media was removed and cells were washed twice with ice
cold PBS. This was followed by a PBS addition and cell scrapping. The cells were
then ressuspended and centrifuged at 800g for 10 minutes at 0ºC. The supernatant
was removed and ice cold Neurobasal media with 25 U/mL Pen/Strep, 0.5mM
glutamine and 10% FBS was added. The Falcon tube was placed on ice followed by
a cell counting procedure using an haemocytometer. Neurons were further
centrifuged at 800g for 10 minutes at 0ºC, the supernatant removed and
ressuspended at a final density of 3x106 cells / mL in Freezing media (DMEM with
20% FBS and 10% DMSO). The cell solution was then aliquoted and the aliquots
were frozen o/n in an isopropanol chamber until they reached -80ºC. They were then
transferred to a storing box and kept at -80ºC until necessary. (For a more detailed
standard cells protocol please refer to Annex II)
40
4. Results and Discussion
4.1 – The Oxidative Comet Assay: Implementation and Optimization
For the implementation and optimization of the comet assay in the laboratory
several issues had to be overcome. The major ones and their solutions are thus
addressed in the following topics.
The first attempts at implementing this technique used the THP-1 tumour cell line
as it was readily available and was more resistant in culture than the primary
neurons.
One of the initial problems was the discovery that the glass slides originally used
had a defect and auto-fluoresced. The solution was to use Superfrost Rosa® slides,
available in the laboratory, instead of plain ones. Early versions of the comet assay
used fully frosted slides instead of agarose-coated plain ones and are reported to
achieve a good gel anchorage. However, high background fluorescence due to a
light scattering effect on the frosted surface and the need of constant refocusing to
acquire comets on different planes was noted [17]. The usage of superfrosted slides in
conjunction with an NMA markedly reduced background fluorescence and did not
require constant refocus to acquire comet images. This is probably due to the
smoother surface of superfrosted slides, when compared with fully frosted ones, and
to the NMA coating that provides a separation and plane levelling from the
superfrosted slide to the comets. Albeit more expensive than the use of plain coated
slides, an increased gel anchorage was observed with this method.
41
The optimization of the agarose percentage on gels, both for the NMA and LMPA
was found to be of 1% and 0.7%, respectively. These percentages allowed a good
anchorage of the gels to the glass slides throughout the experiment.
For transporting the slides throughout the experiment, a dark moisture box was
built that protected the samples from light induced DNA damage and preserved both
moisture and fluorescence at different stages of the assay.
Although most comet assay protocols instruct the storage of the assay solutions at
4ºC, several fungal contaminations were observed and were prevented by storing the
solutions at -20ºC.
In order to test if the assay was working, the THP-1 cells were treated with various
concentrations of etoposide. This compound is a genotoxic agent that induces DNA
damage through the inhibition of the topoisomerase II. It is a highly toxic compound,
which quickly induces DNA damage in cells [26]. As such, it was used to assess if the
technical procedures allowed the observation and quantification of DNA damage, and
whether the assay could be used to discriminate between different levels of damage.
As seen in Figure 13, as the concentration of etoposide increases so does the tail
length and percentage of DNA in tail of the obtained comets. Of note that the comet
data does not fit a normal distribution but instead are better fitted in the Weibull
probability distribution. The consequence of this is that at least 30 comets must be
acquired per experimental condition as implicated in the central limit theorem. This
theorem implicates that all distributions are approached to the normal distribution as
the sample size increases [28].
42
In Figure 14 the mean values obtained for the tail length of the analysed comets
are shown. As can be seen in the panel B, the tail length parameter quickly rises and
soon reaches a plateau in which no further damage can be distinguished. Indeed
near half maximal damage is already atained with the first concentration of etoposide
used (1 µM). In the panel C the mean value of tail length at 50 µM is excluded which
removes the plateau effect on the graph. Although the tail length parameter is
extremely sensitive and discriminative between very low amount of damage, its
progression is not linear [16]. In the oxidative comet assay, the slide incubated with
FPG allows the detection of both structural and oxidative damage while the non
treated slide only allows the detection of the structural DNA damage. In principle, it
Figure 13 – Comet assay using the THP-1 cell line after incubation with etoposide for
one hour at several concentrations. A – 0 µM; B – 1 µM; C – 5 µM; D – 10 µM; E – 50 µM.
A B C
D E
43
would be possible to infer the oxidative DNA damage by simply subtracting these
values but if the data does not follow a linear progression such calculation will give
inacurate quantitive results, when subctracting different values of structural DNA
damage [16].
A quantitative analysis can still be performed in a particular condition: if the values
of tail length for structural DNA damage are constant between two different
Figure 14 – Graphic representations of the comet assay tail length data using the THP-
1 cell line after incubation with etoposide for one hour at several concentrations (n=1;
30 comets in average per slide). A – Histogram of the mean tail length values; B – Scatter
plot with a fitted tendency line to the mean tail length values; C – Scatter plot with a fitted
tendency line to the mean tail length values excluding the mean value at 50 µM.
CTRL 1 5 10 500
100
200
300
400
Tail Length
Etoposide (µM)
Tail
Len
gth
(µ
m)
A Tail Length
0 20 40 60
0
100
200
300
400
Etoposide (µM)
Tail
Len
gth
(µ
m)
B
Tail Length
0 5 10 15
0
100
200
300
400
Etoposide (µM)
Tail
Len
gth
(µ
m)
C
44
Figure 15 – Graphic representations of the comet assay percentage of DNA in tail data
using the THP-1 cell line after incubation with etoposide for one hour at several
concentrations (n=1; 30 comets in average per slide). A – Histogram of the mean % of
DNA in tail values; B – Scatter plot with a fitted tendency line to the mean % of DNA in tail
values; C – Scatter plot with a fitted tendency line to the mean % of DNA in tail values
excluding the mean value at 50 µM.
CTRL 1 5 10 500
20
40
60
80
100
% DNA in Tail
Etoposide (µM)
% D
NA
in
Tail
A % DNA in Tail
0 20 40 60
0
20
40
60
80
100
Etoposide (µM)
% D
NA
in
Tail
B
% DNA in Tail
0 5 10 15
0
20
40
60
80
100
Etoposide (µM)
% D
NA
in
Tail
C
experimental conditions, their oxidative values may be directly compared. This is due
to the fact that subtracting constant structural damage values to the total DNA
damage indicates that the deviation to the linearity of the total DNA damage values
will exclusively be derived from the oxidative damage.
Another situation in which a similar, although qualitative, analysis can be performed
is when the deviation to the linearity occurs in the same direction in both structural
45
and oxidative DNA damage for the two different conditions. If both structural and total
DNA damage values have a tendency to increase between the different experimental
conditions, then the oxidative DNA damage values must have the same tendency.
The same is valid if the tendency between the experimental conditions is a decrease
both in structural and total DNA damage values.
Regarding the percentage of DNA in tail, whose results can be seen in Figure 15, it
is indicated as the most versatile parameter as not only determines the greatest
amplitude of damage levels but does not saturate either into a plateau upon reaching
the maximum DNA damage discerned by the assay [16].
It is important to highlight, as becomes evident by comparing graphs B and C of
Figure 15, that the linear progression of this parameter is proven at least up to 70%
of DNA damage but according to Collins (2004), in theory, it can even reach 100%.
This allows for a quantitative determination of the oxidative DNA damage values,
unfortunately for low amounts of damage this parameter is not as accurate as the tail
length [16].
After determining that the assay was correctly functioning with the THP-1 cell line,
the procedure was adapted to the primary cultured rat cortical neurons. One of the
first problems in this adaptation was the insufficient number of cells available. This
was overcome with the use of a centrifuge with a swinging-bucket rotor which
allowed for a greater number of available neurons concentrated at the end of the
centrifugation tube.
46
A greater problem however, was the quality of the comets obtained. Instead of the
well-defined comets obtained earlier with the THP-1 cell line, these often appeared
“blurred” and “blasted” and unsuitable for analysis as shown in Figure 16. A paper by
the author that described the alkaline comet assay, proposed a parallel assay whose
purpose is to determine the percentage of apoptotic cells, allowing the differentiation
between necrotic and apoptotic ones [49]. The necrotic halos shown in that paper
have a great resemblance to the comets obtained in these initial experiments. The
causes for these “blurred” comets were then found to be related to the use of the
thermoblock and to the strong ressuspension during the cells agarose embedment
step. The thermoblock, which allowed for a less rushed cell embedment step using
the THP-1 cell line, proved to be contributing to neuronal necrosis probably due to a
quick temperature increase. The strong ressuspension in the LMPA agarose
increased this necrotic process as the neurons are highly sensitive to the shearing
forces of such a high density media.
Once the assay was successfully adapted to primary cultured neurons, it was
necessary to ensure that it was reliable and consistent in terms of results, as well as
to have an idea of the variability associated with the assay. To this end, Collins
A B
Figure 16 – Image of comets obtained from primary cultured cortical neurons exposed
to H2O2. A – Normal comet; B – “Blurred” or “Blasted” comet.
47
Tail Length
Structural Damage Oxidative Damage
0
100
200
300
400
Tail
Len
gth
(µ
m)
A % DNA in Tail
Structural Damage Oxidative Damage0
20
40
60
80
100
% D
NA
in
Tail
B
Figure 17 – Graphic representations of the standard cells tail length and percentage of
DNA in tail data mean values (70 comets in average per slide). A – Box and whiskers plot
of the mean tail length values (n=3); B – Box and whiskers plot of the mean % of DNA in tail
values (n=5).
suggests the use of standard cells [16]. These comprise a greater batch of the same
cells as the ones used in the assay, subjected to the same exposure compound,
aliquoted, frozen at -80ºC and used in all subsequent assays. The use of standard
cells would then give the same amount of damage in each assay and any deviation
from these values would indicate that some aspects of the assay had changed [16].
For the present work, the standard cells consisted of a large batch of cultured
neurons exposed to a 30 µM concentration of H2O2 for 30 minutes, then scraped,
counted, aliquoted into microcentrifuge tubes with Freezing Media and frozen at -
80ºC.(See Annex II)
The use of standard cells removes the variability associated with the use of
different cultures and, as such, detects the small intrinsic variations associated with
performing the assay at different times. The mean values for all measurements of
48
both structural and oxidative DNA damage in the standard cells can be observed in
Figure 17.
Regarding the structural DNA damage, in panel A and B of Figure 17, it can be
concluded that in different experiments performed in different days the results from
the standard cells are consistent, presenting a low variation either for the tail length,
with a mean value of about 150 µm, and the percentage of DNA in tail, with a mean
value of about 31%. For the oxidative DNA damage values in graph A of Figure 17,
the calculated mean tail length is 56 µm. However, as previously described, this
parameter is not accurate for calculating the oxidative damage as it does not follow a
linear progression. This mean value of 56 µm, although consistent, can only be
regarded as a qualitative measurement in arbitrary units, rather than a true
quantitative one. Of note that two experiments were removed from the tail length data
set as their respective slides had debris present and these were regarded by the
analysis software Casp as belonging to the comets. These debris than distorted the
analysis of the tail length parameter as their fluorescence intensity falsely increased
the tail length of the obtained comets, but as their DNA amount is very low, its effect
is negligible when considering the percentage of DNA in tail. Considering the panel B
in Figure 17, the oxidative DNA damage has a mean value of 36% DNA in tail. The
consistency of both this value and the mean tail length value, for oxidative DNA
damage, suggests a correct implementation of the incubation with FPG in the comet
assay. These results can thus provide a reliable proof of the assay effectiveness and.
correct implementation.
49
Several published papers and comet assay protocols specify an electrophoretic
voltage of 24 or 25 volts and a current of 300 mA, but fail to include the calculation of
the amount of voltage per cm across the gel. Thus, the electric field driving the DNA
migration can, and often is, different between different studies due to different
electrophoretic chamber dimensions [18]. Ideally the voltage per centimetre should be
0.8 V/cm as referred [48], however some papers use electrophoretic forces as low as
0.4 [34] and up to 1.5 V/cm [36,51]. The calculation for the present work indicates the
use of 1.48 volts per cm which is acceptable [48].
4.2 – Cell Culture Characterization: Are the cultured neurons viable at the
times of the experiment? What percentage of glial cells is present in culture?
In order to ensure the validity of the results obtained through usage of the comet
assay and determine the metabolic viability of the cultured neurons, two experiments
using Alamar Blue® were performed. At DIV 1, DIV 5, DIV 9 and DIV 10, the cultured
neurons were incubated with a 10% Alamar Blue® solution for one hour. At the end of
the incubation period, the fluorescence and absorbance values were determined
which correspond to the conversion of resazurin into resorufin by the reductive
environment produced by the living cells. These values are thus dependent of both
the viability and metabolic rates.
Since Alamar Blue® in effect measures the metabolic activity of cultured cells it is
not a true viability assay as many variables are at play. Its use has been employed to
50
assess cell viability after exposure to a toxic compound as well as to assess cell
proliferation and even the cells metabolic rate [11].
As observed in Figure 18, the obtained results evidence an increasing reductive
environment during the cells maturation in culture which would be compatible with
cell proliferation. However neurons are post-mitotic cells unable to proliferate. This
can have two different non-exclusive explanations, one being increased metabolic
activity in mature neurons, the other being the proliferation of non-neuronal cells such
as astrocytes and glial cells.
Previous experiments in the laboratory performed by A. Santos (2009) have
previously addressed the issue of astrocyte and glial contamination in the exact
same experimental conditions. This was assessed through an immunocytochemistry
assay using an anti-MAP-2 antibody which labels neurons and an anti-GFAP
antibody labelling both glial cells and immature neurons and also using DAPI to label
the cell nucleus [46].
Figure 18 – Graphics of the fluorescence and absorbance data obtained at various DIVs.
The fluorescence values were obtained at 590nm and the absorbance values at 570nm.
Fluorescence
DIV 1 DIV 5 DIV 9 DIV 100
5000
10000
15000
20000
Arb
itra
ry U
nit
s
Absorbance
DIV 1 DIV 5 DIV 9 DIV 100.030
0.035
0.040
0.045
0.050
0.055
0.060
Arb
itra
ry U
nit
s
51
His findings shows that at DIV 4, 80% of the total cells are neurons and at DIV 10
the neuronal percentage has been reduced to 50%, the rest corresponding to glial
cells either reactive labelled with GFAP, or non-reactive and thus only visible through
DAPI labelling [46]. This has been confirmed with immunocytochemistry experiments
performed in this study, results being depicted in Figures 19 and 20.
Figure 19 – Overview of a neuronal culture. Immunocytochemistry assay performed at DIV
5 (A) and at DIV 10 (B). Images obtained at a magnification of 100X. Neurons shown in green
labelled with the anti-MAP-2 antibody (λ=488nm) and astrocytes as well as immature neurons
shown in red labelled with the anti-GFAP antibody (λ=568nm). Non-reactive glial cells are
visible only through DAPI staining.
Figure 20 – Detail of an astrocyte at the
centre of the image. Immunocytochemistry
experiment performed at DIV 5. Image
obtained at a magnification of 400X.
Neurons shown in green labelled with the
anti-MAP-2 antibody (λ=488nm) and
astrocytes as well as immature neurons
shown in red labelled with the anti-GFAP
antibody (λ=568nm). Non-reactive glial cells
are visible only through DAPI staining.
A B
52
AraC is a nucleoside analog (cytosine arabinoside) that is used to induce apoptosis
in mitotic cells and as such obtain pure neuronal cultures, but is known that araC also
exerts an apoptotic effect in postmitotic neurons by two distinct mechanisms [1].
Initially at DIV 3 and at each subsequent media change, araC was added to the
culture medium at a final concentration of 10 µM. However, this greatly reduced the
culture viability and several morphologic changes were visible in the culture such as
neuronal aggregates. This alone greatly increased the difficulties of performing the
comet assay with mature neurons as the available number of cells after scrapping
became very low, and with a high prevalence of cellular debris.
Another reason against the usage of pure neuronal cultures for the comet assay
was indicated by the fact that the tail length of the comets appeared greater in the
preliminary experiments (data not shown) which could be derived from the action
mechanism of the araC compound. The purpose of the comet assay is to evaluate
DNA damage and thus it can be very sensitive to the presence of this compound in
culture.
Besides the increased technical difficulties of using pure neuronal cultures, the
araC compound is known to inhibit the DNA repair mechanisms [62] and thus may
alter the basal level of DNA damage present in cultured cells which explains the
increased levels of DNA damage measured by comet assay. This increased amount
of basal DNA damage in cultures would lead to difficulties in comparing results
between cultures of different DIVs as the period of exposure to araC would differ.
Even then, obtained results could not be attributed with certainty to the effects of the
53
Aβ peptide 25-35 or the H2O2, and the question of possible interaction or cumulative
effects with the araC would remain. In light of the above, the disadvantages of using
pure neuronal cultures far outweigh the advantages and as such araC was not added
to the cultures for the remaining experiments.
In the interest of culture characterization it would also have been useful to ascertain
the neuronal viability after exposure to the Aβ peptide 25-35 or the H2O2.
Experiments using Alamar Blue® to assess the neuronal viability after exposure to
H2O2 were indeed performed. However the results were not coherent as both the
fluorescence and absorbance values were wildly variable (data not shown). This can
probably be explained due to the oxidative nature of H2O2 and the possible effect of
BDNF on the regulation of the activity of antioxidant enzymes in neurons [32]. The
exposure to H2O2 possibly alters the reductive environment of cells and since Alamar
Blue® is a redox-sensitive dye thus making this assay unreliable to measure cell
viability [11,65].
An equivalent experiment for the Aβ peptide 25-35 was not conducted. However
there are published results for similar experimental conditions to those of this study
both for neuronal viability after exposure to H2O2 [22] and to the Aβ peptide 25-35
[2].
Neuronal cultured cells were exposed to either 10 µM of H2O2 for 10 minutes at DIV
10, in the comet assay experiments, or 30 µM for 30 minutes at DIV 3 for the
standard cells [see Annex II]. At the referred conditions of H2O2 exposure, Hoyt et al
report that the cell viability, for the comet assay experiments, would be around 50%,
while for the standard cells the cell viability would be approximately zero. Despite the
54
similarities between both studies, it is important to note that these calculations were
based on DIV 14 cultures and that cellular viability was only assessed after a 20 hour
period post exposure. These authors then calculated neuronal viability through a cell
counting method in which the non-exposed cultures were compared with cultures
exposed at various H2O2 concentrations and time periods [22].
Other authors such as Schwartz et al, used DIV 4 rat cortical neurons incubated
with 5 µM and 100 µM H2O2 for a up to 24 hour time period to study to induction of
repairable or non-repairable DNA damage. Their data reveals that the 5 µM proved
non-toxic for DIV 4 neurons while the 100 µM H2O2 induced a loss of viability of 60%
when incubated for a 24 hour period [47].
As such, these viability values cannot be directly compared to the present study.
Both during the comet assay and the standard cells preparation the cells are washed
twice in ice cold PBS after toxic exposure, the culture plate is placed over ice and all
subsequent procedures until cell lysis or cell freezing occur at near 0ºC. This slows
the cells metabolism and either the assay is performed with cells kept in this state, or
in the case of the standard cells, the neurons are frozen to -80ºC. Although some
necrosis is possible, it is thus unlikely that apoptotic procedures and nuclear
degradation can occur during the chosen toxic exposure time frame [4].
Regarding the effects of the Aβ peptide25-35 on neuronal viability, a paper by
Arancibia et al (2008) describes the cell death after exposure to various
concentrations of Aβ25-35 during a 48 hour period [2]. They determined that exposure
to the Aβ25-35 for a prolonged period of time has a significant effect upon neuronal
55
Figure 21 – Graphic representation of structural and oxidative DNA damage as the
neuronal culture matures. Comet assay performed at DIV 5 (n=3), DIV 9 (n=6) and DIV 10
(n=2). The values refer to the medium tail length of the comets acquired. In average, 70
comets per slide were obtained at DIV 5 and DIV 9 and 120 comets at DIV 10.
viability however for low concentrations such as up to 5 µM the cell viability is still
greater than 80%. The authors then described these concentrations as sub-lethal.
Since the main purpose of the present study is to obtain data on the oxidative DNA
damage of neuronal cells, sub-lethal concentrations of Aβ25-35 of up to 3 µM were
selected and the exposure time limited to a 24 hour period.
4.3 – Do neurons accumulate DNA damage, either structural or oxidative, as
they mature in culture?
The evidence that cells accumulate oxidative damage in eukaryotic organisms as
they age has been in the foundation of the oxidative theory of ageing. Several studies
have found some evidence that supports this theory [59]. As neurons mature in
culture, does their nuclear DNA become more oxidized? In order to answer this
question, the DNA damage data from the control slides of DIV 5, DIV 9 and DIV 10
were compared.
As can be seen in Figure 21, the tail length has a tendency to increase as the
56
neurons mature in culture, suggesting that neurons do accumulate both oxidative and
structural DNA damage. However, it is important to remember that these conclusions
can only be drawn by the analysis of tail length values. Considering the percentage
of DNA in tail (see Figure 22), these conclusions are not evident as it appears that
both oxidative and structural DNA damage is maintained unaltered as the neurons
mature in culture. As referred above in 4.1 (The Oxidative Comet Assay:
Implementation and Optimization), the tail length parameter should be preferred as it
is known that for low amounts of damage, it presents a greater sensitivity despite that
after a certain amount of damage it also reaches a plateau.
Despite the consistent results, the question remains whether the accumulation of
oxidative damage does occur regardless of the use of the B27 supplement in the
culture media. As previous studies referred, this supplement might protect neurons
from apoptosis [41] when exposed to the Aβ25-35, and as such, the media was
DIV 5 DIV 9 DIV 10
0
20
40
60
80
100
Structural % of DNA in Tail
% D
NA
in
Tail
DIV 5 DIV 9 DIV 10
0
20
40
60
80
100
Oxidative % of DNA in Tail
% D
NA
in
Tail
Figure 22 – Graphic representation of structural and oxidative DNA damage as the
neuronal culture matures. Comet assay performed at DIV 5 (n=3), DIV 9 (n=6) and DIV 10
(n=2). The values refer to the medium percentage of DNA in tail of the comets acquired. In
average, 70 comets per slide were obtained at DIV 5 and DIV 9 and 120 comets at DIV 10.
57
removed 48h prior to the comet assays and replaced with fresh media without B27.
This two day period of starving was a compromise between the total removal of the
B27 supplement from the culture media, which would lead to cell death and thus
impair the acquisition of results from mature neurons, and the maintenance of this
supplement which, as reported before, could protect the neurons and mask any DNA
damage induced by either the Aβ25-35 or the H2O2.
CTRL 1 µµµµM Aββββ 1 µµµµM Aββββ w/ B27
0
20
40
60
80
100
Structural % DNA in Tail
% D
NA
in
Tail
CTRL 1 µµµµM Aββββ 1 µµµµM Aββββ w/ B27
0
50
100
150
200
250
Oxidative Tail Length
Tail
Len
gth
(µ
m)
CTRL 1 µµµµM Aββββ 1 µµµµM Aββββ w/ B27
0
20
40
60
80
100
Oxidative % DNA in Tail
% D
NA
in
Tail
CTRL 1 µµµµM Aββββ 1 µµµµM Aββββ w/ B27
0
50
100
150
200
250
Structural Tail Length
Tail
Len
gth
(µ
m)
A B
C D
Figure 23 – Graphic representation of structural and oxidative DNA damage caused in
the presence of the Aβ25-35 and in the presence or absence of the B27 supplement.
Comet assay performed at DIV 5 (70 comets in average per slide, n=3; except for the
experimental condition without B27 supplement – n=2). The values refer to the mean values
of the comet parameters, tail length and percentage of DNA in tail. A – Histogram of the
structural damage tail length mean values; B – Histogram of the structural damage
percentage of DNA in tail mean values; C – Histogram of the oxidative damage tail length
mean values; D – Histogram of the oxidative damage percentage of DNA in tail mean values.
58
Regardless of the chosen compromise, the presence of B27 could even alter the
basal levels of DNA damage which in turn could invalidate the obtained results.
However, experiments conducted with the Aβ25-35 in the presence and absence of
B27 at DIV 5 and DIV 9, revealed that this supplement appears to have no effect
whatsoever. As seen in the different panels shown in Figures 23 and 24, the amount
CTRL 1 µµµµM Aββββ 1 µµµµM Aββββ w/ B27
0
50
100
150
200
250
Structural Tail Length
Tail
Len
gth
(µ
m)
CTRL 1 µµµµM Aββββ 1 µµµµM Aββββ w/ B27
0
20
40
60
80
100
Structural % DNA in Tail
% D
NA
in
Tail
CTRL 1 µµµµM Aββββ 1 µµµµM Aββββ w/ B27
0
50
100
150
200
250
Oxidative Tail Length
Tail
Len
gth
(µ
m)
CTRL 1 µµµµM Aββββ 1 µµµµM Aββββ w/ B27
0
20
40
60
80
100
Oxidative % DNA in Tail
% D
NA
in
Tail
A B
C D
Figure 24 – Graphic representation of structural and oxidative DNA damage caused in
the presence of the Aβ25-35 and in the presence or absence of the B27 supplement.
Comet assay performed at DIV 9 (70 comets in average per slide, n=3; except for the
experimental condition without B27 supplement – n=2). The values refer to the mean values
of the comet parameters, tail length and percentage of DNA in tail. A – Histogram of the
structural damage tail length mean values; B – Histogram of the structural damage
percentage of DNA in tail mean values; C – Histogram of the oxidative damage tail length
mean values; D – Histogram of the oxidative damage percentage of DNA in tail mean values.
59
of DNA damage, either structural or oxidative, is the same either in the presence or
absence of the B27 supplement for all comet parameters.
An increase in the basal levels of both structural and oxidative DNA damage is
present when comparing between the DIV 5 and DIV 9, this increase is however the
same for all experimental conditions. This implies that the removal of B27
supplement 48 hours prior to assay did not exert an effect upon the basal levels of
DNA damage.
Although further studies would be necessary to obtain statistical significance, it is
probable that neurons do accumulate both structural and oxidative DNA damage as
they mature in culture or have increasingly higher levels of basal DNA damage due
to less effective DNA repair mechanisms.
4.4 – Does Aβ25-35 peptide induce structural and/or oxidative DNA damage at
sub-lethal concentrations?
Several studies in recent years [2,37] have found a significant neuronal death when
primary cultured neurons are exposed to both Aβ1-42 and Aβ25-35 peptides. However,
the concentrations used ranged around 20 µM for periods of 48 hours [2,37].
In the present work, the Aβ25-35 concentration was far below, reaching only 3 µM
and the exposure time was reduced to 24 hours. These conditions were chosen as
the objective of this work was to determine whether the Aβ25-35 caused oxidative DNA
damage in sub-lethal concentrations.
60
The mechanisms by which the Aβ peptide exerts its effects it is not yet fully
understood. In vitro studies have, however, demonstrated the ability of Aβ1-42 to
induce the production of H2O2 using Cu2+ and other ions even in the absence of cells.
On the other hand, in the same conditions, the Aβ25-35 proved unable to do so [24]. In
spite of this, Aβ25-35 can cause protein oxidation [58] and thus we asked whether it
could cause nuclear DNA damage.
The interest of this peptide was even reinforced by the report that in AD brains
there is a twofold increase in DNA strand breaks and that the levels of oxidized DNA
bases are increased, particularly 8-OHdG [58].
As seen in Figure 25 and 26, the data suggests that incubation with Aβ25-35 (3 µM)
for 24 hours has no effect on either structural or oxidative DNA damage. Regarding
the DIV 5 data in Figure 25, it shows no difference on the levels of DNA damage
between the control and the experimental conditions. The same situation is observed
at DIV 9 in Figure 26. Although there is a difference between the basal levels of
damage between DIV 5 and DIV 9 neurons, as the DNA at DIV 9 has greater
structural and oxidative damage, this corresponds to the normal culture maturation
process and it is not related to the Aβ25-35 exposure. Of note the necessity of
evaluating the oxidative damage through the percentage of DNA in tail parameter
when comparing between DIVs, as the oxidative tail length parameter cannot be
compared due to the different amounts of structural damage and the non-linearity of
this parameter previously described.
61
These results can be explained by two non-mutually exclusive phenomena. Either:
1) the Aβ25-35 exposure concentrations were too low to cause DNA damage, the cells
being able to completely repair DNA damage at the studied concentrations; 2) or the
Aβ25-35 although able to cause protein oxidations is not able to induce DNA damage.
Figure 25 – Graphic representation of structural and oxidative DNA damage caused by
sub-lethal concentrations of Aβ25-35. Cultured cells exposed to Aβ25-35 at DIV4; Comet assay
performed at DIV 5 (70 comets in average per slide, n=3). The values refer to the mean
values of the comet parameters, tail length and percentage of DNA in tail. A – Histogram of
the structural damage tail length mean values; B – Histogram of the structural damage
percentage of DNA in tail mean values; C – Histogram of the oxidative damage tail length
mean values; D – Histogram of the oxidative damage percentage of DNA in tail mean values.
B
CTRL 0.3 µµµµM Aββββ 1 µµµµM Aββββ 3 µµµµM Aββββ
0
20
40
60
80
100
Structural % DNA in Tail
% D
NA
in
Tail
D
CTRL 0.3 µµµµM Aββββ 1 µµµµM Aββββ 3 µµµµM Aββββ
0
20
40
60
80
100
Oxidative % DNA in Tail
% D
NA
in
Tail
CTRL 0.3 µµµµM Aββββ 1 µµµµM Aββββ 3 µµµµM Aββββ
0
50
100
150
200
250
Structural Tail Length
Tail
Len
gth
(µ
m)
A
CTRL 0.3 µµµµM Aββββ 1 µµµµM Aββββ 3 µµµµM Aββββ0
50
100
150
200
250
Oxidative Tail Length
Tail
Len
gth
(µ
m)
C
62
Some published data indicates the ability of the Aβ25-35 to induce structural DNA
damage to primary cultured cortical neurons. However, this is not easily accessed as
the paper is written in chinese with only an english abstract available. The available
data reports that the use of 25 µM of Aβ25-35 only induced a very small level of
structural DNA damage and the oxidative DNA damage was not determined. Further
CTRL 0.3 µµµµM Aββββ 1 µµµµM Aββββ 3 µµµµM Aββββ
0
50
100
150
200
250
Structural Tail Length
Tail
Len
gth
(µ
m)
A
CTRL 0.3 µµµµM Aββββ 1 µµµµM Aββββ 3 µµµµM Aββββ
0
50
100
150
200
250
Oxidative Tail Length
Tail
Len
gth
(µ
m)
C
B
CTRL 0.3 µµµµM Aββββ 1 µµµµM Aββββ 3 µµµµM Aββββ
0
20
40
60
80
100
Structural % DNA in Tail
% D
NA
in
Tail
D
CTRL 0.3 µµµµM Aββββ 1 µµµµM Aββββ 3 µµµµM Aββββ
0
20
40
60
80
100
Oxidative % DNA in Tail
% D
NA
in
Tail
Figure 26 – Graphic representation of structural and oxidative DNA damage caused by
sub-lethal concentrations of Aβ25-35. Cultured cells exposed to Aβ25-35 at DIV8; Comet assay
performed at DIV 9 (70 comets in average per slide, n=3). The values refer to the mean
values of the comet parameters, tail length and percentage of DNA in tail. A – Histogram of
the structural damage tail length mean values; B – Histogram of the structural damage
percentage of DNA in tail mean values; C – Histogram of the oxidative damage tail length
mean values; D – Histogram of the oxidative damage percentage of DNA in tail mean values.
63
studies, at a higher concentration of Aβ25-35, are thus necessary to determine its
effect upon nuclear DNA damage.
4.5 - Does BDNF protect against H2O2 induced DNA damage?
As the Aβ25-35 peptide did not induce DNA damage in cultured rat cortical neurons
at the sub-lethal concentrations tested, the neuroprotective effect of BDNF upon
induced DNA damage could not be studied. I therefore assessed the putative
protective effect of BDNF by exposing neurons to a stronger oxidizing agent, H2O2, a
known product of Aβ1-42 in vivo.
The results illustrated in Figure 27 clearly show increased levels of DNA damage
on neurons exposed to 10 µM H2O2 for 10 minutes. As with the results from the
exposure to the Aβ25-35 peptide care must be taken to interpreter the tail length
parameter information. Regarding the structural damage evaluated through tail length
it is important to note that neurons exposed to H2O2 as well as neurons pre-incubated
with BDNF for 48 hours show similar levels of structural damage. However, H2O2 is a
strong oxidizing agent and therefore, the tail length parameter has already reached
its plateau phase, precluding any conclusion based upon this parameter. This is
consubstantiated when analysing the oxidative tail length parameter, as reading the
data at face value would imply that H2O2 as well as a BDNF pre-incubation followed
by H2O2 exposure would decrease the basal levels of oxidative damage. This is an
artefact, in reality the increased tail length in the control condition, visible in the panel
C, corresponds to the tail length parameter reaching its plateau in the FPG incubated
64
slide (structural + oxidative damage) and having the non-plateau value of the non-
FPG incubated slide subtracted from it, the other conditions having reached the
plateau in the non-incubated slide.
Figure 27 – Graphic representation of structural and oxidative DNA damage after
exposure to H2O2 with or without a pre-incubation with BDNF. Comet assay performed at
DIV 10 (120 comets in average per slide, n=2). The values refer to the mean values of the
comet parameters, tail length and percentage of DNA in tail. A – Histogram of the structural
damage tail length mean values; B – Histogram of the structural damage percentage of DNA
in tail mean values; C – Histogram of the oxidative damage tail length mean values; D –
Histogram of the oxidative damage percentage of DNA in tail mean values. * – p<0.05; ** –
p<0.01; Φ – p<0.05.
CTRL H2O2 H2O2 + BDNF0
50
100
150
200
250
Structural Tail Length
*
Tail
Len
gth
(µ
m)
A
CTRL H2O2 H2O2 + BDNF0
50
100
150
200
250
Oxidative Tail Length
Tail
Len
gth
(µ
m)
C
CTRL H2O2 H2O2 + BDNF
0
20
40
60
80
100
Structural % DNA in Tail
** *% D
NA
in
Tail
B
CTRL H2O2 H2O2 + BDNF
0
20
40
60
80
100
Oxidative % DNA in Tail
φ
***%
DN
A i
n T
ail
D
65
Due to the strong oxidizing nature of H2O2, the percentage of DNA in tail parameter
is the most suitable for analysis since it allows the discrimination of the widest range
of DNA lesions for the assay. Figure 28 shows a detail of the data set seen in Figure
27 regarding this parameter and as can be seen, H2O2 exposure increased both
structural and oxidative DNA damage. These values are statistically significant with a
p-value of less than 0.01. Most importantly, however, is the fact that the H2O2
exposed and BDNF incubated neurons had reduction in the DNA damage levels
when compared to those exposed to H2O2 but not incubated with BDNF. Although
this reduction is small and not statistically significant regarding the structural damage,
for the oxidative DNA damage a statistically significant decrease (p<0.05) was
observed. It is apparent that the BDNF protection is more effective in oxidative DNA
damage rather than in structural damage. This probably occurs due to the increased
activity levels of antioxidant enzymes, especially the glutathione reductase and
glutathione peroxidase, that is known to occur after pre-incubation with BDNF [32].
CTRL H2O2 H2O2 + BDNF
0
10
20
30
Structural % DNA in Tail
** *
% D
NA
in
Tail
CTRL H2O2 H2O2 + BDNF
0
10
20
30
Oxidative % DNA in Tail
φ
**
*
% D
NA
in
Tail
Figure 28 – Graphic representation of structural and oxidative DNA damage after
exposure to H2O2 in the presence or absence of BDNF. Comet assay performed at
DIV 10 (120 comets in average per slide, n=2). The data refers to the mean values of the
percentage of DNA in tail parameter. * – p<0.05; ** – p<0.01; Φ – p<0.05.
66
A control experiment without exposure to H2O2 but with incubation with BDNF was
performed (data not shown, n=1). However, debris were present in the FPG
incubated slide and a single experiment could not be directly compared to the other
data sets. As this lead to the compromise of the oxidative tail length parameter these
values were not represented in Figure 27. While the percentage of DNA in tail
parameter indicates that BDNF has no adverse effect upon neuronal DNA and may
in fact slightly protect against basal structural DNA damage (data not shown), further
experiments are necessary to confirm this.
Recent studies regarding DNA repair and apoptosis of cortical neurons in the
presence of H2O2 [47,57] have been reported as well as BDNF protection of apoptosis
in the presence of the same compound [5]. Terminally differentiated neurons have
been shown to activate the cell cycle machinery and to undergo the G0 → G1
transition to efficiently repair induced DSB [47,57]. Blockage of this transition, in
neurons exposed to lethal concentrations of H2O2 impaired both DNA repair as well
as apoptosis [47,57], however, blockage of the G1 → S transition prevented apoptosis
without impairing DNA repair [47]. Neurons exposed to sub-lethal concentrations of
H2O2 were also shown to undergo the G0 → G1 transition, but not the G1 → S [47].
There is also evidence that G0 → G1 transition may be influenced by the cytoplasmic
concentration of H2O2 via ERK signalling [7].
Studies that look upon the signalling pathways of BDNF neuroprotection often use
co-administration with high concentrations of H2O2 to study its effect on apoptosis.
There is in fact evidence that points to the anti-apoptotic effect of BDNF signalling via
MAPK/ERK in oxidative stress conditions and via PI3-K/Akt, as well as MAPK/ERK,
67
in excitotoxic stress [5]. BDNF is thought to have an inhibitory effect upon the
MAPK/ERK pathway activated by oxidative stress [5]. This is possibly derived from
the effect of KSR1 on ERK1/2 preventing its nuclear localization and leading to an
inhibition of phosphorylation of the pRb and release of the E2F1 which mediates the
G1 → S transition and leads to apoptosis [5,12,54].
The data obtained in this study however, suggests that BDNF protection of nuclear
DNA occurs independently of BDNF anti-apoptotic effects. Although BDNF is most
likely also exerting its anti-apoptotic effect upon neurons, the experimental design
and time frame does not allow for apoptosis to occur.
68
5. Conclusions
The comet assay was correctly implemented in primary rat cortical neurons, which
allows future studies on DNA damage in neurons, and even glial cells, to be
performed in the laboratory.
Although not statistically significant, a tendency depicting that mature neurons have
higher, although still low, levels of DNA damage, both structural and oxidative, when
compared with DNA damage levels of more immature ones was found. This was
expected as a body of evidence refers that aged cells in vivo have their nuclear DNA
in a more damaged state, especially regarding oxidative DNA damage.
The Aβ25-35 peptide was not found to induce DNA damage of any kind at the tested
sub-lethal concentrations. This may be due to the low concentrations used,
comparing with most in vitro studies, and higher concentrations should be tested to
account for this possibility. Or, the Aβ25-35 peptide may be unable to induce nuclear
DNA damage of any kind, especially since it does not appear to induce the formation
of the highly diffusible and damaging H2O2.
H2O2 was found to induce both structural and oxidative DNA damage as was
expected. The BDNF was found to produce a significant protective effect upon the
nuclear DNA of neurons. To this date and to my knowledge, no other studies have
attempted to determine the BDNF effect on oxidative DNA damage. The collected
data thus presented the first direct observation that BDNF can protect against
nuclear DNA damage, particularly of the oxidative kind.
69
6. Future Work
Further experiments to characterize the culture regarding its maturation should be
performed to confirm the data and attain statistical significance. Neurons at latter
DIVs such as 15 should also be tested.
The Aβ25-35 peptide did not cause oxidative DNA damage at the tested sub-lethal
concentrations. The experiments should be repeated in higher concentrations of the
peptide to see if oxidative damage appears, or if only structural damage, which may
be derived from the earlier stages of apoptosis.
The Aβ1-42 peptide should also be tested due to its ability to form H2O2 in the
presence of copper. Its mechanism of action upon the cell is different and although
oxidative DNA damage was not present at sub-lethal concentrations with the Aβ25-35
peptide, it can be present with the Aβ1-42 peptide.
The BDNF DNA damage protection is probably due to the increase in activity of the
antioxidant enzymes GPx and GR, but this evidence could be consolidated by
repeating the experiments in the presence of selective enzyme inhibitors, or
glutathione depleting agents such as, ethacrynic acid and buthionine sulfoximine
[21,45]. Identification of the signalling pathway, PI3K/Akt, PLC-γ or MAPK/ERK,
responsible for DNA damage protection through the use of inhibitors for the above
pathways such as LY-294002, U-73122 and U-0126 respectively would also be of
interest.
70
In addition, although BDNF plays a role in preventing apoptosis of DNA damaged
neurons, which effect does it have on DNA repair? If BDNF prevents neurons from
exiting G0 into G1, which is thought to be dependent upon pRb and the cyclin
C/CDK3 complex [57], it could have a detrimental effect upon DNA repair as neuronal
cells re-enter the cell cycle to repair their DNA. However, if BDNF only blocks the
G1→S transition, dependent upon pRb and the cyclin E/CDK2 complex [57], its effect
could either be beneficial, with an elevated activity of repair mechanisms when
compared with neurons not incubated with BDNF, or neutral if the DNA repair
efficiency is the same. This could be measured by comet assay, for example with
neurons pre-incubated with a glutathione depleting agent in the presence or absence
of BDNF and exposed to H2O2 at low, non-lethal, concentrations. Performing the
oxidative comet assay at different time frames, would allow for the determination of
BDNF effect upon DNA repair mechanisms [64].
71
7. References
1 Anderson, C., & Tolkovsky, A. (1999). A role for MAPK/ERK in sympathetic neuron survival: protection against a p53-dependent, JNK-independent induction of apoptosis by cytosine arabinoside. The Journal of Neuroscience, 19(2), 664-673.
2 Arancibia, S., Silhol, M., Moulière, F., Meffre, J., Höllinger, I., Maurice, T., & Tapia-Arancibia, L. (2008). Protective effect of BDNF against beta-amyloid induced neurotoxicity in vitro and in vivo in rats. Neurobiology of Disease, 31, 316-326.
3 Bohr, V. A. (2002). Repair of oxidative DNA damage in nuclear and mitochondrial DNA, and some changes with aging in mammalian cells. Free Radical Biology & Medicine, 32(9), 804-812.
4 Bonfoco, E., Krainc, D., Ankarcrona, M., Nicotera, P. & Lipton, S. A. (1995). Apoptosis and necrosis: Two distinctive ends induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proceeding of the National Academy of Sciences, USA, 92, 7162-7166.
5 Boutahar, N., Reynaud, E., Lassabliere, F., & Borg, J. (2010). Brain-Derived Neurotrophic Factor Inhibits Cell Cycle Reentry but Not Endoplasmic Reticulum Stress in Cultured Neurons Following Oxidative or Excitotoxic Stress. Journal of Neuroscience Research, 88, 2263-2271.
6 Brasnjevic, I., Hof, P. R., Steinbusch, H. W. M., & Schmitz, C. (2008). Accumulation of nuclear DNA damage or neuron loss?: Molecular basis for a new approach to understanding selective neuronal vulnerability in neurodegenerative diseases. DNA Repair, 7, 1087-1097.
7 Burhans, W. C., & Heintz, N. H. (2009). The cell cycle is a redox cycle?: Linking phase-specific targets to cell fate. Free Radical Biology and Medicine, 47, 1282-1293.
8 Butterfield, D. A., & Boyd-Kimball, D. (2005). The critical role of methionine 35 in Alzheimer's amyloid β-peptide (1-42)-induced oxidative stress and neurotoxicity. Amyloid International Journal of Experimental and Clinical Investigation, 1703, 149-156.
9 Butterfield, D. A., & Kanski, J. (2002). Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid β-peptide 1-42. Peptides, 23, 1299-1309.
10 Cemeli, E., Baumgartner, A., & Anderson, D. (2009). Antioxidants and the Comet assay. Mutation Research, 681, 51-67.
11 Chakrabarti, S., Vitseva, O., Iyu, D., Varghese, S. & Freedman, J. E. (2005). The Effect of Dipyridamole on Vascular Cell-Derived Reactive Oxygen Species. The Journal of Pharmacology and Experimental Therapeutics, 315(2), 494-500.
12 Chambard, J.-C., Lefloch, R., Pouysségur, J., & Lenormand, P. (2007). ERK implication in cell cycle regulation. Biochimica et Biophysica Acta, 1773, 1299-1310.
13 Chen, A. F., Davies, C. M., De Lin, M., & Fermor, B. (2008). Oxidative DNA damage in osteoarthritic porcine articular cartilage. Journal of Cellular Physiology, 217(3), 828-833.
72
14 Chen, J., Hales, C. N. & Ozanne, S. E. (2007) DNA damage, cellular senescence and organismal ageing: causal or correlative? Nucleic Acids Research, 35(22), 7417-7428.
15 Chu, C. T., Levinthal, D. J., Kulich, S. M., Chalovich, E. M., & Defranco, D. B. (2004). Oxidative neuronal injury: The dark side of ERK1/2. European Journal of Biochemistry 271(11), 2060-2066.
16 Collins, A. R. (2004). The comet assay for DNA damage and repair: principles, applications, and limitations. Molecular Biotechnology, 26(3), 249-61.
17 Collins, A. R. (2011). Chapter 8: The Use of Bacterial Repair Endonucleases in the Comet Assay. Drug Safety Evaluation: Methods and Protocols, Methods in Molecular Biology, 691, USA, Springer Science+Business Media, LLC.
18 Collins, A. R., Oscoz, A. A., Brunborg, G., Gaivão, I., Giovannelli, L., Kruszewski, M., Smith, C. C. & Stetina, R. (2008). The comet assay: topical issues. Mutagenesis, 23(3), 143-151.
19 Farooqui, T., & Farooqui, A. A. (2009). Aging: an important factor for the pathogenesis of neurodegenerative diseases. Mechanisms of ageing and development, 130, 203-215.
20 Fu, W., Lu, C., & Mattson, M. P. (2002). Telomerase mediates the cell survival-promoting actions of brain-derived neurotrophic factor and secreted amyloid precursor protein in developing hippocampal neurons. The Journal of Neuroscience, 22(24), 10710-10709.
21 Harper, M. M., Adamson, L., Blits, B., Bartlett, M., Grozdanic, S. D., & Sakaguchi, D. S. (2009). Brain-derived neurotrophic factor released from engineered mesenchymal stem cells attenuates glutamate and hydrogen peroxide-mediated death of staurosporine-differentiated RGC-5 cells. Experimental Eye Research, 89, 538-548.
22 Hoyt, K. R., Gallagher, A. J., Hastings, T. G. & Reynolds, I. J. (1997). Characterization of hydrogen peroxide toxicity in cultured rat forebrain neurons. Neurochemical Research, 22(3), 333-340.
23 Huang, E. J. & Reichardt, L. F. (2003). Trk Receptors: Roles In Neuronal Signal Transduction. Annual Review Biochemistry, 72, 609-642.
24 Huang, X., Cuajungco, M. P., Atwood, C. S., Hartshorn, M. A., Tyndall, J. D. A., Hanson, G. R., Stokes, K. C., Leopold, M., Multhaup, G., Goldstein, L. E., Scarpa, R. C., Saunders, A. J., Lim, J., Moir, R. D., Glabe, C., Bowden, E. F., Masters, C. L., Fairlie, D. P., Tanzi, R. E. & Bush, A. I. (1999). Cu(II) potentiation of Alzheimer Aβ Neurotoxicity - Correlation with cell-free hydrogen peroxide production and metal reduction. The Journal of Biological Chemistry. 274(52), 37111-37116.
25 Ichim, G., Tauszig-Delamasure, S. & Mehlen, P. (2012) Neurotrophins and cell death. Experimental Cell Research, 318, 1221-1228.
26 Kruman, I. I., Wersto, R. P., Cardozo-Pelaez, F., Smilenov, L., Chan, S. L., Chrest, F. J., Emokpae, E. Jr., Gorospe, M. & Mattson, M. P. (2004). Cell Cycle Activation Linked to Neuronal Cell Death Initiated by DNA Damage. Neuron, 41, 549-561.
27 Kumaravel, T. S., Vilhar, B., Faux, S. P., & Jha, A. N. (2009). Comet Assay measurements?: a perspective. Cell Biology and Toxicology, 25, 53-64.
73
28 Lovell, D. P., & Omori, T. (2008). Statistical issues in the use of the comet assay. Mutagenesis, 23(3), 171-182.
29 Luo, Y., & Defranco, D. B. (2006). Opposing Roles for ERK1/2 in Neuronal Oxidative Toxicity: Distinct Mechanisms of Erk1/2 Action at Early Versus Late Phases of Oxidative Stress. The Journal of Biological Chemistry, 281(24), 16436-16442.
30 Martin, L. J. (2008). DNA damage and repair: relevance to mechanisms of neurodegeneration. Journal of Neuropathology and Experimental Neurology, 67(5), 377-87.
31 Mattson, M. P. (2008). Glutamate and Neurotrophic Factors in Neuronal Plasticity and Disease. Annual New York Academy of Science, 1144, 97-112.
32 Mattson, P., Lovell, A., Furukawa, K., & Markesbery, W. R. (1995). Neurotrophic Factors Attenuate Glutamate-Induced Accumulation of Peroxides, Elevation of Intracellular Ca2+ Concentration, and Neurotoxicity and Increase Antioxidant Enzyme Activities in Hippocampal Neurons. Journal of Neurochemistry, 65, 1740-1751.
33 Maynard, S., Schurman, S. H., Harboe, C., Souza-pinto, N. C. & Bohr, V. A. (2009). Base excision repair of oxidative DNA damage and association with cancer and aging. Carcinogenesis, 30(1), 2-10.
34 Mishra, D., & Flora, S. J. S. (2008). Differential oxidative stress and DNA damage in rat brain regions and blood following chronic arsenic exposure. Toxicology and Industrial Health, 24, 247-256.
35 Moris, E. J., Dreixler, J. C., Cheng, K.-Y., Wilson, P. M., Gin, R. M. & Geller, H. M. (1999). Optimization of Single-Cell Gel Electrophoresis (SCGE) for Quantitative Analysis of Neuronal DNA Damage. Circle Reader Service, 26(2), 178-184.
36 Murali, S., Pulukuri, K., Knost, J. A., Estes, N., & Rao, J. S. (2009). Small Interfering RNA - Directed Knockdown of Uracil DNA Glycosylase Induces Apoptosis and Sensitizes Human Prostate Cancer Cells to Genotoxic Stress. Molecular Cancer Research, 7(8), 1285-1293.
37 Nie, B.-M., Jiang, X.-Y., Cai, J.-X., Fu, S.-L., Yang, L.-M., Lin, L., Hang, Q., Lu, P.-L. & Lu, Y. (2008). Panaxydol and panaxynol protect cultured cortical neurons against Abeta25-35-induced toxicity. Neuropharmacology, 54, 845-53.
38 Nilsen, J. (2008). Estradiol and neurodegenerative oxidative stress. Frontiers in Neuroendocrinology, 29, 463-475.
39 Osterod, M., Hollenbach, S., Hengstler, J. G., Barnes, D. E., Lindahl, T., & Epe, B. (2001). Age-related and tissue-specific accumulation of oxidative DNA base damage in 7, 8-dihydro-8-oxoguanine-DNA glycosylase (Ogg1) deficient mice. Carcinogenesis, 22(9), 1459.
40 Patterson, C., Feightner, J. W., Angeles Garcia, A., Hsiung, G.-Y. R., MacKnight, C. & Sadovnick, A. D. (2008). Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease. Canadian Medical Association Journal, 178(5), 548-556.
41 Perry, S. W., Norman, J. P., Litzburg, A., & Gelbard, H. A. (2004). Antioxidants Are Required During the Early Critical Period, But Not Later, for Neuronal Survival. Journal of Neuroscience Research, 78, 485-492.
74
42 Piperakis, S. M., Kontogianni, K., Karanastasi, G., Kritsi, Z. I. & Piperakis, M. M. (2009). The use of comet assay in measuring DNA damage and repair efficiency in child, adult and old age populations. Cell Biology and Toxicology, 25, 65-71.
43 Rajawat, Y. S., Hilioti Z. & Bossis, I. (2009). Aging: Central role for autophagy and the lysosomal degradative system. Ageing Research Review, 8, 199-213.
44 Reichardt, L. F. (2006). Neurotrophin-regulated signalling pathways. Philosophical Transactions of the Royal Society, 361, 1545-1564.
45 Rizzardini, M., Lupi, M., Bernasconi, S., Mangolini, A., & Cantoni, L. (2003). Mitochondrial dysfunction and death in motor neurons exposed to the glutathione-depleting agent ethacrynic acid. Journal of The Neurological Sciences, 207, 51-58.
46 Santos, A. J. (2009). Influência dos receptores A2A da adenosina no efeito neuroprotector do BDNF na morte neuronal induzida. Master Thesis. Faculdade de Ciências - Universidade de Lisboa.
47 Schwartz, E. I., Smilenov, L., Price, M. A., Osredkar, T., Baker, R. A., Ghosh, S., Shi, F., Vollmer, T. L., Lencinas, A., Stearns, D. M., Gorospe, M. & Kruman, I. I. (2007). Cell Cycle Activation in Postmitotic Neurons is Essential for DNA Repair. Cell Cycle, 6(3), 318-329.
48 Shaposhnikov, S., Thomsen, P. D., & Collins, A. R. (2011). Chapter 10: Combining Fluorescent In Situ Hybridization with the Comet. DNA Damage Detection In Situ, Ex Vivo, and In Vivo: Methods and Protocols, Methods in Molecular Biology, 682, USA, Springer Science+Business Media, LLC.
49 Singh, N. P. (2005). Chapter 4: Apoptosis assessment by the DNA diffusion assay. Methods in Molecular Medicine, 111(2). Totowa, NJ, Humana Press Inc.
50 Skaper, S. D. (2012). Chapter 1: The Neurotrophin Family of Neurotrophic Factors: An Overview. Neurotrophic Factors: Methods and Protocols, Methods in Molecular Biology, 846, USA, Springer Science+Business Media, LLC.
51 Srujana, K., Begum, S. S., Rao, K. N., Devi, G. S., Jyothy, A., & Prasad, M. H. (2010). Application of the comet assay for assessment of oxidative DNA damage in circulating lymphocytes of Tetralogy of Fallot patients. Mutation Research, 688, 62-65.
52 Stanciu, M. & Defranco, D. B. (2002). Prolonged Nuclear Retention of Activated Extracellular Signal-regulated Protein Kinase Promotes Cell Death Generated by Oxidative Toxicity or Proteasome Inhibition in a Neuronal Cell Line. The Journal of Biological Chemistry,277(6), 4010-4017.
53 Su, B., Wang, X., Nunomura, A., Moreira, P. I ., Lee, H., Perry, G. Smith, M. A & Zhu, X. (2008) Oxidative Stress Signaling in Alzheimer's Disease. Current Alzheimer Research, 5(6), 525-532.
54 Szatmari, E., Kalita, K. B., Kharebava, G., & Hetman, M. (2007). Role of Kinase Suppressor of Ras-1 in Neuronal Survival Signaling by Extracellular Signal-Regulated Kinase 1 / 2. Journal of Neuroscience, 27(42), 11389-11400.
75
55 Tapia-Arancibia, L., Aliaga, E., Silhol, M., & Arancibia, S. (2008). New insights into brain BDNF function in normal aging and Alzheimer disease. Brain Research Reviews, 59, 201-220.
56 Thomas, C., Mackey, M. M., Diaz, A. A. & Cox, D. P. (2009). Hydroxyl radical is produced via the Fenton reaction in submitochondrial particles under oxidative stress: implications for diseases associated with iron accumulation. Redox Report, 14(3), 102-108.
57 Tomashevski, A., Webster, D. R., Grammas, P., Gorospe, M., & Kruman, I. I. (2010). Cyclin C-dependent cell cycle entry is required for activation of nonhomologous end joining DNA repair in postmitotic neurons. Cell Death & Differentiation 17(7), 1189-1198.
58 Varadarajan, S., Yatin, S., Aksenova, M. & Butterfield, D. A. (2000). Alzheimer's amyloid β-peptide-associated free radical oxidative stress and neurotoxicity. Journal of Structural Biology, 130, 184-208.
59 Vijg, J. (2007). Aging of the Genome - The Dual Role of DNA in Life and Death. Oxford, Oxford University Press.
60 Vilhar, B. (2004) Help! There is a comet in my computer! A dummy's guide to image analysis used in the comet assay. Accessed in September 2010. Available at: http://botanika.biologija.org/exp/comet/comet_guide01.pdf
61 Waldbaum, S., & Patel, M. (2010). Mitochondria, oxidative stress, and temporal lobe epilepsy. Epilepsy Research, 88, 23-45.
62 Wasson, G. R., McKelvey-Martin, V. J. & Downes, C. S. (2008). The use of the comet assay in the study of human nutrition and cancer. Mutagenesis, 23(3), 153-162.
63 Wei, F., Yan, J. & Tang, D. (2011). Extracellular Signal-Regulated Kinases Modulate DNA Damage Response - A Contributing Factor to Using MEK Inhibitors in Cancer Therapy. Current Medicinal Chemistry, 18, 5476-5482.
64 Yang, J.-L., Tadokoro, T., Keijzers, G., Mattson, M. P., & Bohr, V. a. (2010). Neurons efficiently repair glutamate-induced oxidative DNA damage by a process involving CREB-mediated up-regulation of apurinic endonuclease 1. The Journal of Biological Chemistry, 285(36), 28191-28199.
65 Zhou, M., Diwu, Z., Panchuk-Voloshina, N. & Haugland, R. P. (1997). A stable nonfluorescent derivative of resorufin for the fluorometric determination of trace hydrogen peroxide: Application in detecting the activity of phagocyte NADPH oxidase and other oxidases. Analytical Biochemistry, 253, 162-168.
76
8. Annexes
Annex I – Comet Assay Working Protocol for Structural and Oxidative DNA
Damage
• Buffers:
o PBS :
(Ca2+ Mg2+ free, pH 7.4)
Stock 10X
Stock 1X
Working Solution
- 80.0 g NaCl
- 2.0 g KCl
- 11.5 g Na2HPO4
- 2.0 g KH2PO4
- Add 900 mL of H2O Elix
- Adjust pH to 7.4
- Adjust volume to 1000 mL
- Sterilize by autoclaving
- Store at room temperature
- 100 ml of Stock Solution 10X
- Add 850 mL H2O Elix
- Adjust pH to 7.4
- Adjust volume to 1000 mL
- Store at room temperature
- Transfer 100 mL to a
Labelled Sterile 100 mL
Schott Flask in the laminar
flow unit
- Store at room temperature
- Refrigerate in an Ice/Water
Bath 30 min before use
o Lysis Solution :
(2.5 M NaCl, 100 mM EDTA, 10 mM Tris, 1% Triton X-100, pH 10)
Stock 1X
Working Solution (Fresh before use)
- 146.1 g NaCl
- 37.224 g EDTA
- 1.2110 g Trizma base
- 8.0 g NaOH (Use plastic spatula;
Hygroscopic)
- Add 850 mL of H2O Elix
- Dissolve for 20 minutes with
agitation
- Adjust pH to 10
- Adjust volume to 1000 mL
- Prepare and label 5x 200 mL Schott
flasks
- Freeze and Store at - 20°C
- Thaw an aliquot of 200 mL of the Stock
Solution in a Water Bath (37ºC)
- Prepare two P1000 Blue Tips with the
point cut
- Add 2 ml of Triton X-100 to the bottle with
the tips
- Stir the solution gently and horizontally
- Place on Ice/Water Bath for more than 30
min prior to use Note: Due to the high density of Triton X-100, firstly
cover the inner surface of the prepared tip by pipetting
up and down once. Then pipette 1 mL Triton X-100
very slowly to ensure the correct volume is added to
the solution.
77
o FPG Solutions :
(100 mM KCl, 40 mM HEPES, 500 µM EDTA, 200 µg/mL BSA, pH 8)
FPG Stock Solution10X
FPG Reaction Solution 1X - 66.724 g HEPES
- 52.185 g KCl
- 1.303 g EDTA
- 1.4 g BSA
- Adjust pH to 8.0 with KOH (5 M)
- Adjust volume to 700 mL
- Aliquot the solution into (10 + 10) 50
and 15 mL Falcon tubes
- Store the remaining volume in 1500 µL
eppendorfs in equal number to available
FPG enzyme stock aliquots
- Freeze and Store at -20ºC
- Thaw two Falcon Tubes (50 + 15 mL) of
FPG Stock Solution
- Transfer the solution to a 1 L Schott flask
- Add 585 mL of H2O Elix
- Correct pH to 8.0 with KOH (5 M)
- Add water to a volume of 650 mL
- Store overnight at 4ºC in the cold room
FPG Stabilization Solution 1X
Note: The FPG Stabilization Solution is necessary at
very small volumes at each time. Its use is to, after
dispensing the FPG Enzyme Stock Solution, kindly
provided by Dr. Andrew Collins, into 5 µL aliquots,
dilute one of the aliquots at 1:100 and further dispense
into 25 aliquots of 20 µL (100x diluted). All aliquots
must be immediately stored at -80ºC as FPG is
unstable. The 100x diluted aliquots are further diluted
at 1:30 with reaction solution and used one per assay.
- Thaw an eppendorf of FPG Stock
Solution and transfer 1 mL into a 50 mL
Falcon tube.
- Add 1 mL pure glycerol
- Adjust pH to 8 with KOH (1 M)
- Adjust volume to 10 mL
o Electrophoresis Solution :
(300 mM NaOH, 1 mM EDTA, pH > 13)
NaOH Stock 1X (Fresh every two weeks)
EDTA Stock 1X (Fresh every two weeks) - 27.79 g NaOH
- Add 150 mL of H2O Elix
- Dissolve for 10 minutes with agitation in
the hood
- Adjust volume to 200 mL
- Remove and discard 10 mL solution
- Transfer the 190 mL to a labelled 200
mL Schott flask
- Store at 4ºC for up to two weeks
- 1.23 g EDTA
- Add 13 mL of H2O Elix
- Adjust pH to 10 while dissolving with
agitation
- Adjust volume to 15 mL
- Transfer 10 mL to a labelled 15 mL Falcon
tube
- Store at 4ºC for up to two weeks
78
H2O Elix
Working Solution (Fresh before use) - Measure 2 L of H2O Elix
- Store at room temperature
- Refrigerate all Stocks and the H2O Elix to
4ºC overnight in the cold room
- Mix all Stocks and water into a 2 L
Erlenmeyer
o Neutralization Buffer :
(400 mM Tris, pH 7.5)
Stock 1X
Working Solution (Fresh before use) - 24.25 g Tris Base
- Add 400 mL H2O Elix
- Dissolve with agitation
- Adjust pH to 7.5 with HCl (6-10 M)
- Adjust volume to 500 mL
- Transfer 50 mL to 10x Labelled 50 mL
Falcon tubes
- Freeze and Store at - 20°C
- Remove an aliquot of Lysis Solution
- Thaw the Neutralization Solution overnight
at room temperature prior to use
o Staining Solution :
(0.4 µg/mL EtBr)
Working Solution (Fresh before use) - Fill one Falcon tube with 25 mL H2O Elix
- Involve the Falcon with aluminium paper
- Pipette 1 µL of EtBr stock solution (10 mg/mL)
to the Falcon
- Close Falcon and vortex
79
• Agarose:
o NMA – Normal Melting Agarose :
(1%)
Aliquots
Working Solution
- Weight 250 mg of NMA accurately in
an eppendorf
- Repeat this process for the amount
of aliquots necessary for future
experiments
- Transfer the 250 mg aliquot to a 25 mL
Schott flask
- Add 25 mL of PBS (Working Solution)
- Use a portion of the solution to thoroughly
wash the eppendorf, removing the
remaining NMA to the Schott flask
- Heat the solution in the microwave with the
lid half open for periods of 30s until all lumps
are completely dissolved
- Store at room temperature until necessary
o LMPA – Low Melting Point Agarose :
(0,7%)
Aliquots
Working Solution
- Weight 175 mg of LMPA accurately
in an eppendorf
- Repeat this process for the amount
of aliquots necessary for future
experiments
- Transfer the 175 mg aliquot to a 25 mL
Schott Flask
- Add 25 mL of PBS (Working Solution)
- Use a portion of the solution to thoroughly
wash the eppendorf, removing the
remaining LMPA to the Schott flask
- Heat the solution in the microwave with the
lid half open for periods of 30s until all lumps
are completely dissolved
- Store at room temperature until necessary
80
• Protocol:
o Preparation of microscope slides:
Preparation
- Place 200 mL of Absolute Ethanol in a 250 mL goblet
- Modulate the Bünsen air entry to produce a blue flame
- Place 12 Superfrost Rosa® slides and around 15 coverslips on tissue
papers for easy access
- Prepare an ice tray, smoothing the ice surface with a metal plate and
leaving the latter to ensure an even temperature
Slide Cleaning and Coating
- Dip both the slides and coverslips in the ethanol
- Wipe them gently with a tissue paper
Do the following procedure to no more than 4 slides at the time:
- Heat the NMA solution in the microwave with an open lid and use shortly
after it stops boiling
- With a tweezer, dip the slides one at a time in ethanol and burn them over
the blue flame to remove dust and machine oil
- Add 210 µL NMA and the 24x60 mm coverslip to the slide accordingly to
the outline of Figure A.
81
- Place the slide in the ice tray for 5 minutes
- Remove the coverslip with a dissection tweezer accordingly to the outline
in Figure B.
- Place the slide on a flat surface
- Repeat the procedure for the other 3 slides
Repeat the above procedure for the remaining slides
- Allow the slides to dry overnight on a flat surface or, preferably, on a
previously prepared (dry at this time) aluminium-foil covered moisture box
and place the lid to avoid dust deposition and ease of transport
- Label the slides
Figure A – Outline of the slide cleaning and coating first steps. 1 – Add the NMA to
one side of the slide; 2 – Introduce the cover slip and drag the NMA to the left; 3 – Allow
the cover slip to spread the NMA across the slide without any air bubbles.
Figure B – Outline of the slide cleaning and coating last steps. 1 – Place the slide in
the ice tray for 5 minutes; 2 – Remove the coverslip with a dissection tweezer.
82
o Cell preparation and lysis:
Cell Culture
- Remove the culture media
- Wash the cells two times with ice cold PBS to stop cell metabolism and
especially DNA repair
- Place the culture plate on an ice tray
- For each experimental condition, scrape the cells with a cell scraper and 1
mL ice cold PBS (take care to scrape cells only once with the scraper at
90º angle and firm hand to avoid cell membrane rupture)
- Transfer the PBS with the cells to a labelled 15 mL falcon tube
- Wash the cell plate well with another mL of PBS and add to the falcon
- Place the falcon on an easily movable ice box (with a bit of water on the
box bottom)
- Rinse the cell scraper and repeat for the other experimental conditions
Cell Suspension
- Refrigerate a 15 mL falcon tube centrifuge with a swinging-bucket rotor to
0º C for at least 30 minutes before initiating the following step
- Centrifuge at 700 g for 10 minutes (acceleration 7; brake 3)
- Return the falcon tubes to the ice box
- For each tube, remove the supernatant by tilting
83
- Add 100-80 µL PBS and very carefully ressuspend the pellet (for the
experimental conditions at DIV 5 and DIV 9-10, it corresponds to a cellular
density of approximately 7.5x105 cells per mL)
- Return the tube to the ice box and repeat for the other conditions
Standard Cells Suspension (Optional)
- Refrigerate a eppendorf centrifuge to 4º C for at least 30 minutes before
initiating the following step
- Take a Standard Cells aliquot (prepared as in Annex II) from the -80ºC
freezer
- Add 400 µL of ice cold PBS to the eppendorf but do not ressuspend
- Centrifuge at 800g for 10 minutes (4ºC)
- Remove 300 µL from the upper liquid carefully
- Ressuspend ( 120 µL final volume, cellular density 5 x 105 cells per mL)
- Immediately place the eppendorf on ice or ice/water bath
Agarose Embedment and Cell Lysis
- Regulate a water bath to 37º C and allow it to stabilize the temperature
- Prepare the working lysis solution and refrigerate it on an ice/water bath for
at least 30 minutes prior to use
- Heat the LMPA solution in the microwave with an open lid and place on the
water bath at 37º for at least 15 minutes prior to use
- Place 12 0,5 mL eppendorfs on an eppendorf support on the water bath at
37º C to normalize their temperature
84
Figure C – Outline of the agarose embedment and cell lysis steps. 1 – Place the LMPA
in the centre of the slide, setting it into an oval shape; 2 – Press the coverslip directly on top
of the agarose; 3 – The LMPA should cover the NMA completely.
- Prepare an ice tray, smoothing the ice surface with a metal plate and
leaving the latter to ensure an even temperature
Do the following procedure for each slide, one each time:
- Very carefully ressuspend the cells in the falcon tube
- With one micropipette add 10 µL of cell suspension to a heated eppendorf
- With another micropipette (with care to pipette the LMPA down and up
again to remove air bubbles) add 75 uL LMPA to the heated eppendorf
- Do NOT ressuspend the cell and agarose mixture (this is CRITICAL
especially when working with sensitive cells such as neurons as the
shearing forces of the cells subjected to movement in an higher density
medium will burst, and nuclear membrane rupture occurs resulting in DNA
degradation from cytoplasmic nucleases)
- Place the corresponding slide on a flat surface
- Transfer the 85 µL from the eppendorf to the slide and press a clean 24x60
mm coverslip over it according to the outline of Figure C.
85
- Place the slide on the metal plate over the ice tray for at least 5 minutes
Repeat the above procedure for the remaining slides
- Transfer the working lysis solution to an opaque coplin jar
- Remove coverslips from each slide on the tray and place them on the
coplin jar, on ice, for 1h 30 min
- Transport the coplin jar to the cold room
o Oxidative damage determination:
Preparation
- Prepare the FPG Reaction Solution the day before and leave it overnight
on the cold room
- Place all the necessary material in the cold room: 200 µL micropipette and
tips; an ice tray with a metal plate on top; 1 L goblet for waste; Falcon tube
support; several paper tissues and 24x60 mm clean coverslips on a paper
tissue for easy access
- Soak the transport and incubation moist box with some water and place it
in the incubator at 37ºC
- Remove an aliquot of 100x diluted FPG from the -80ºC freezer and
transport it to the cold room on ice.
- Dilute it with 580 µL (1:30) with FPG Reaction Solution, ressuspending a
bit and place it on ice once again.
- Fill one other eppendorf with FPG reaction solution only and place it on ice
86
FPG Incubation
- After 1h 30 min, remove the slides from the coplin jar and remove the lysis
solution to the waste
- Fill the coplin jar with approximately 200 mL of FPG Reaction Solution and
wash the slides for 5 minutes
- Repeat the previous step twice
- Remove the slides one at a time (starting with the structural damage only)
- Over the bench on a paper tissue add 115 µL of FPG Reaction Solution or
FPG Reaction Solution + FPG from the eppendorfs as appropriate , cover
with a coverslip and immediately place over the metal plate on the ice tray
- Repeat the procedure for all the slides
- Cover the ice tray with aluminium foil to minimize the exposure to light
- Transport the slides out of the cold room to near the incubator
- Place the slides in the moist box in the incubator for 30 minutes
o Electrophoresis:
Preparation
- Place the stock solutions and Elix water for the electrophoresis solution in
the cold room overnight to normalize their temperature
- Prepare the working lysis solution in an 2000 mL Erlenmeyer by gentle
mixing with a plastic pipette
87
- Ensure the electrophoresis chamber is perfectly level with a carpenters
bubble
- Cover the top of the electrophoresis chamber with aluminium foil or a black
cloth to prevent light-induced DNA damage
- Add the working electrophoresis solution to the chamber wells only
DNA Unwinding and Electrophoretic Run
- Remove the slides from the moist box in the incubator to the metal plate on
the ice tray to stop the reaction and cover with aluminium foil to preserve
from light induced DNA damage
- Transport the slides to the cold room and remove the coverslips
- Place the slides side-by-side on the centre of the electrophoresis chamber
(fill with extra empty slides if necessary
- Add more working electrophoresis solution to cover the slides (Total
Volume approximately 2100 mL) and use a tweezer to gently press on the
slides to dislodge any bubbles
- Replace the chamber lid and wait 20 minutes as the DNA unwinds
- Input the electrophoresis parameters (24 V for 30 minutes)
- Adjust the electrophoresis solution volume with a plastic pipette (by quickly
starting and stopping the electrophoresis) such as at the end of the
unwinding step the current amounts to 300 mA
- Start the electrophoresis (30 minutes)
88
- When finished, remove the slides to a flat tray with 7-10 paper tissues for
transport and proceed to neutralization (no care to shield the slides from
light induced damage is necessary from this point onwards)
o Neutralization and Dehydration:
Neutralization
- Using a pipette, drop wise coat Neutralization Buffer on top of the slides
and allow to sit for 5 minutes
- Drain the slides onto the paper tissues on the tray and repeat the
procedure twice more
Dehydration
- Previously chill an ethanol series (70%, 95% and Absolute Ethanol) on ice
( 200 mL each in Schott Flasks in order to completely cover slides on the
coplin jar)
- Add the 70% ethanol solution to the coplin jar and transfer the slides to it
for the duration of 5 minutes
- Remove the slides and ethanol solution and repeat the procedure twice
more, with the 95% and Absolute Ethanol solutions
- Air dry the slides overnight or on an oven at 50ºC for 30 minutes
- Store the slides in dry area protected from dust or proceed to staining
89
o Staining and Image Acquisition:
Staining
- Prepare the Staining Solution
- Clean at least 20 coverslips ( dip coverslips on ethanol and wipe with a
paper tissue once to remove grease and dust from stock coverslips) and
place them over a paper tissue for easy access
- Prepare the aluminium foil covered moist box for transport of stained slides
by adding water
- Add sufficient ice to a big ice box capable of transport of the moist box
Do the following procedure to no more than 4 slides at the time:
- Add 40 µL of Staining Solution to each slide and cover with a clean
coverslip making sure all the gel is covered with Staining Solution
- Wait 5 minutes and remove the coverslip
- Remove the excess stain with an Elix water wash bottle
- Add 50 µL of Elix water to the slide and cover with a clean coverslip
according to the outline of Figure D.
- Transfer the slide to the moist box to protect it from drying and light
- Repeat the above procedure for the remaining slides
- Place the moist box in the ice box until the image acquisition step
90
Figure D – Outline of the staining steps. 1 – Add the staining solution to one side of the
slide; 2 – Use a coverslip to spread the staining solution over the slide; 3 – Wait 5 minutes
with the coverslip on top of the slide; 4 – Remove the coverslip; 5 – Wash the staining
solution using a wash bottle and do not let the staining solution touch the back of the slide;
5 – Add the water to one side of the slide and place a clean coverslip on top.
Image Acquisition
- Turn the fluorescence microscope and camera (Axiovert 200M, Roper
Scientific Coolsnap HQ CCD (12-bit))
- Open the control program and use the recommended parameters:
o 400 ms of exposure time as acquired images have been tested and
are not saturated for the experimental conditions;
o 20x objective;
o Pseudo-colour software filter for ease of focus
- Acquire between 50 and 120 comet images per slide (the later number is
recommended as more precise results can be obtained)
91
- Acquire each slide without undue delay as some fluorescence is lost when
exposed to the light from the microscope, the same applies to water
evaporation
Note: Although special care has been taken to ensure the microscope is
not contaminated with ethidium bromide such as using a 5x more diluted
staining solution than normally recommended by Kumaravel (2009) and
removing the excess stain and substituting with water, thoroughly clean the
microscope platform with absolute ethanol to ensure no residual
contamination remains
Storage
- Remove the coverslips with a pair of dissection tweezers
- De-stain the gels with Absolute Ethanol from a wash bottle
- Allow the slides to dry and store in a dry place at room temperature
- For re-examination, re-staining, as above, is necessary
o Data Processing and Analysis:
Image Conversion
- Prepare a copy of the directory of images to be converted (Example:
Results) and name it (Example: Converted Results)
- Open ImageJ
92
Automatic Procedure:
- Drag and open provided Macro “CometConvert.ijm” with ImageJ (or
“CometInvert&Convert.ijm” if a horizontal flip is necessary for comet left-to-
right orientation)
- Select each experimental condition directory at a time within the Converted
Results, and for convenience, select the same directory as destination
- Do NOT alter the minimum and maximum intensities from 0 and 4096
unless greater resolution in the results is necessary (in such situation the
absolute minimum and maximum bit intensity of all images needs to be
analysed for each experiment set and can be defined here)
- Repeat the previous steps for all the experimental conditions
Manual Procedure:
- Open all images to be analysed , one experimental condition / image series
at each time
- Select Image → Adjust → Brightness / Contrast → Set → Imput
parameters Min 0 and Max 4096 → Propagate to All Images
- (If necessary) Select Image → Transform → Flip Horizontally
- Select File → Save as → TIF
- Repeat procedure for all the experimental conditions
- Note: Image conversion is necessary as the TIF files produced upon
acquisition are 16-bit files and the analysis software only accepts 8-bit files.
Since a 12-bit camera was used, only the first 12 bits of the 16-bit files
have information. The algorithm consists of removing the empty bits,
93
flipping the image horizontally if necessary, and converting the information
from 12-bits to the equivalent in 8-bits. Some resolution is lost in this
process but it is negligible as the main advantage of using a 12-bit camera
is to prevent image saturation.
Data Analysis
The analysis software used was CASP (Comet Assay Software Project),
freely available at www.casplab.com)
- Open CASP software
- Select File → Select Files → Select converted images to be analysed
(each experimental condition/image series at each time)
- Select Options → Adjust → Insert parameters Comet Threshold 0.03 and
Profile 2 (No tail cluster) → Set as Default → OK
- Select View → Results Window → Maximize program window → Organize
windows in a comfortable display
- Select a comet from one image, defining the frame size (It must be large
enough to include all comets in the set to be analysed)
- Select Start Measurements
- Use the following commands in order to proceed quickly:
[If necessary Ctrl-W (Flip Comet Frame)] → Ctrl-A (Assay Comet) → Ctrl-Z
(Store Comet) → Next Image
- Select File → Export Results → Name appropriately and add .txt to the end
of the filename → Save
- File → New Series
94
- Repeat procedure for each experimental condition
Data Processing
- Open provided Exel file “Modelo Analise Automatica”
- Name each tab after each experimental condition
- Select Data → Obtain External Data → From Text → Select each data file
at a time → Select parameters Delimited and File Origin 437: United States
OEM → Next → Select Space →Next → Conclude
- Copy data from entry tab to corresponding data set
- Repeat procedure for each experimental condition
Note: If the images were not obtained with Axiovert 200M 20x objective the
bit size value must be altered for a correct determination of the Tail Length
parameter (20x objective bit size = 0.48 µm)
Final Note: To better understand the image acquisition and analysis steps as well as
possible troubleshooting please refer to Vilhar B. (2004) Available at:
http://botanika.biologija.org/exp/comet/comet_guide01.pdf
95
Annex II – Standard Cells Protocol
o Treatment with H2O2
- Culture a large batch of neuronal cells in a Petri dish.
- At DIV 3, treat the cells with 30 µM H2O2.
- Incubate 30 min on ice.
- Remove the medium and wash twice with ice cold PBS.
- Add new PBS and scrape cells on ice to a Falcon tube (50 mL).
o Centrifugation
- Centrifuge at 800g at 0ºC for 10 min.
- Remove the supernatant with a pipette.
- Add 5 mL ice cold Neurobasal (with 25 U/mL Pen/Strep, 0.5mM
glutamine and 10% FBS).
- Ressuspend with the pipette (use blue tips and blue-yellow tips).
- Place the Falcon on ice.
o Cell Count:
- Remove 15 µl of the cell suspension to a 500 µL eppendorf with 30 µl
of Trypan Blue and ressuspend gently.
- Replace Falcon on ice.
- Counting cells in the hemocytometer:
- Cells per mL = average count of 4 fields x 3 x 104
- Calculate the ressuspension:
96
- Total Cells = Cells per mL x Volume in the Falcon
- Volume for Ressuspension = Total Cells / Desired Cell Density
(3x106)
o Ressuspension:
- Centrifuge at 800g at 0ºC for 10 min.
- Remove the supernatant with pipettor.
- Add the calculated Volume for Ressuspension of ice cold Freezing
Medium (DMEM with 20% FBS and 10% DMSO).
- Ressuspend with the pipettor (use blue tips and blue-yellow tips).
- Place the Falcon on ice.
o Freezing:
- Aliquot 20 µL of the ressuspension to 1500 µL microfuge tubes.
- Slowly freeze overnight in a plastic box with isopropanol with support
for microcentrifuge tubes in the -80ºC freezer.
- Transfer the tubes to box in the freezer at -80°C or to Liquid Nitrogen.